Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för 14159, L.p.. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att 14159, L.p. har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:GHDX / Genomic Health, Inc. | Director, 10% Owner | 7 642 042 |
US:INCY / Incyte Corporation | Director, 10% Owner | 281 190 |
US:IDRA / Idera Pharmaceuticals, Inc. | Director, 10% Owner | 89 233 |
US:ACAD / ACADIA Pharmaceuticals Inc. | Director, 10% Owner | 1 569 |
US:BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock) | Director, 10% Owner | 7 102 |
US:XOMA / XOMA Royalty Corporation | 90 538 | |
US:GEVA / Synageva Biopharma Corp | 0 | |
US:SGEN / Seagen Inc | Director, 10% Owner | 21 109 766 |
US:BCRX / BioCryst Pharmaceuticals, Inc. | 10% Owner | 145 533 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av 14159, L.p.. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ACAD / ACADIA Pharmaceuticals Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ACAD / ACADIA Pharmaceuticals Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ACAD / ACADIA Pharmaceuticals Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp BCRX / BioCryst Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ACAD / ACADIA Pharmaceuticals Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ACAD / ACADIA Pharmaceuticals Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp XOMAO / XOMA Royalty Corporation - Preferred Stock - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ACAD / ACADIA Pharmaceuticals Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ACAD / ACADIA Pharmaceuticals Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av 14159, L.p. som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7 642 042 | 0,00 | 67,28 | 24 894 | 514 156 586 | |
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7 642 042 | 0,00 | 67,28 | 24 894 | 514 156 586 | |
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 1 217 279 | 0,03 | 67,28 | 24 894 | 81 898 531 | |
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 244 595 | 0,15 | 67,28 | 24 894 | 16 456 352 | |
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 160 223 | 0,23 | 67,28 | 24 894 | 10 779 803 | |
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −95 289 | 0 | −100,00 | ||||
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | −95 289 | 0 | −100,00 | ||||
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8 341 | 95 289 | 9,59 | ||||
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8 340 | 95 289 | 9,59 | ||||
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | −8 866 | 43 361 | −16,98 | ||||
2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | −7 815 | 165 610 | −4,51 | ||||
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7 641 672 | 0,01 | 58,86 | 24 957 | 449 788 814 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7 641 672 | 0,01 | 58,86 | 24 957 | 449 788 814 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 1 390 806 | 0,03 | 58,86 | 24 957 | 81 862 841 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 418 122 | 0,10 | 58,86 | 24 957 | 24 610 661 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 333 750 | 0,13 | 58,86 | 24 957 | 19 644 525 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 226 124 | 0,19 | 58,86 | 24 957 | 13 309 659 | |
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 13 166 | 13 166 | |||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 7 641 248 | 0,03 | ||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 7 641 248 | 0,03 | ||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 1 390 382 | 0,14 | ||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 417 698 | 0,46 | ||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 333 326 | 0,58 | ||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 225 700 | 0,85 | ||||
2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220 141 | 281 190 | 360,60 | ||||
2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220 141 | 281 190 | 360,60 | ||||
2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | −692 706 | 0 | −100,00 | ||||
2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | −1 603 238 | 2 826 766 | −36,19 | ||||
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12 472 | 12 472 | |||||
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12 472 | 12 472 | |||||
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12 472 | 12 472 | |||||
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1 520 | 812 602 | 0,19 | ||||
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1 520 | 812 602 | 0,19 | ||||
2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1 520 | 812 602 | 0,19 | ||||
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 232 | 7 639 338 | −0,12 | 65,32 | −603 070 | 499 031 352 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 417 | 1 214 575 | −0,12 | 65,32 | −92 564 | 79 340 776 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −244 | 241 891 | −0,10 | 65,32 | −15 939 | 15 801 263 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −142 | 157 519 | −0,09 | 65,32 | −9 276 | 10 289 755 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 | 49 893 | −0,02 | 65,32 | −719 | 3 259 205 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −158 | 171 091 | −0,09 | 65,32 | −10 321 | 11 176 331 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −63 775 | 7 648 570 | −0,83 | 67,13 | −4 281 177 | 513 443 915 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 791 | 1 215 992 | −0,80 | 67,13 | −657 264 | 81 628 813 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 688 | 242 135 | −0,69 | 67,13 | −113 314 | 16 254 377 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −979 | 157 661 | −0,62 | 67,13 | −65 720 | 10 583 688 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −74 | 49 904 | −0,15 | 67,13 | −4 968 | 3 350 026 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 093 | 171 249 | −0,63 | 67,13 | −73 372 | 11 495 843 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −173 085 | 7 712 345 | −2,19 | 64,62 | −11 184 701 | 498 369 420 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −26 575 | 1 225 783 | −2,12 | 64,62 | −1 717 269 | 79 209 730 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 581 | 243 823 | −1,84 | 64,62 | −296 023 | 15 755 769 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 656 | 158 640 | −1,65 | 64,62 | −171 630 | 10 251 269 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −202 | 49 978 | −0,40 | 64,62 | −13 053 | 3 229 563 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 966 | 172 342 | −1,69 | 64,62 | −191 662 | 11 136 688 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −106 054 | 7 885 430 | −1,33 | 66,61 | −7 063 981 | 525 227 990 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −16 282 | 1 252 358 | −1,28 | 66,61 | −1 084 502 | 83 416 310 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 807 | 248 404 | −1,12 | 66,61 | −186 967 | 16 545 545 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 628 | 161 296 | −1,00 | 66,61 | −108 437 | 10 743 507 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −124 | 50 180 | −0,25 | 66,61 | −8 259 | 3 342 359 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 817 | 175 308 | −1,03 | 66,61 | −121 026 | 11 676 810 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −60 618 | 7 991 484 | −0,75 | 67,42 | −4 086 914 | 538 792 244 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 307 | 1 268 640 | −0,73 | 67,42 | −627 485 | 85 532 724 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 604 | 251 211 | −0,63 | 67,42 | −108 143 | 16 936 847 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −930 | 162 924 | −0,57 | 67,42 | −62 701 | 10 984 466 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −71 | 50 304 | −0,14 | 67,42 | −4 787 | 3 391 536 | |
2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 039 | 177 125 | −0,58 | 67,42 | −70 050 | 11 941 909 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −10 832 | 8 052 102 | −0,13 | 69,12 | −748 735 | 556 581 420 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 663 | 1 277 947 | −0,13 | 69,12 | −114 951 | 88 334 892 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −287 | 252 815 | −0,11 | 69,12 | −19 838 | 17 475 205 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −166 | 163 854 | −0,10 | 69,12 | −11 474 | 11 325 998 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −13 | 50 375 | −0,03 | 69,12 | −899 | 3 482 046 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −185 | 178 164 | −0,10 | 69,12 | −12 788 | 12 315 141 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −102 618 | 8 062 934 | −1,26 | 68,70 | −7 049 918 | 553 928 404 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −15 755 | 1 279 610 | −1,22 | 68,70 | −1 082 378 | 87 909 975 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 716 | 253 102 | −1,06 | 68,70 | −186 591 | 17 388 259 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 575 | 164 020 | −0,95 | 68,70 | −108 203 | 11 268 272 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −120 | 50 388 | −0,24 | 68,70 | −8 244 | 3 461 686 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 758 | 178 349 | −0,98 | 68,70 | −120 776 | 12 252 683 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −15 543 | 8 165 552 | −0,19 | 67,68 | −1 051 888 | 552 611 897 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 386 | 1 295 365 | −0,18 | 67,68 | −161 475 | 87 665 122 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −411 | 255 818 | −0,16 | 67,68 | −27 815 | 17 312 739 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −239 | 165 595 | −0,14 | 67,68 | −16 175 | 11 206 807 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −18 | 50 508 | −0,04 | 67,68 | −1 218 | 3 418 179 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −266 | 180 107 | −0,15 | 67,68 | −18 002 | 12 188 921 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 813 | 8 181 095 | −0,02 | 67,87 | −123 047 | 555 244 373 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −278 | 1 297 751 | −0,02 | 67,87 | −18 868 | 88 077 322 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −48 | 256 229 | −0,02 | 67,87 | −3 258 | 17 390 057 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −28 | 165 834 | −0,02 | 67,87 | −1 900 | 11 255 021 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 | 50 526 | 0,00 | 67,87 | −136 | 3 429 159 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −31 | 180 373 | −0,02 | 67,87 | −2 104 | 12 241 771 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −18 661 | 8 182 908 | −0,23 | 67,90 | −1 267 017 | 555 590 813 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 865 | 1 298 029 | −0,22 | 67,90 | −194 523 | 88 131 626 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −494 | 256 277 | −0,19 | 67,90 | −33 541 | 17 400 311 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −286 | 165 862 | −0,17 | 67,90 | −19 418 | 11 261 449 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −22 | 50 528 | −0,04 | 67,90 | −1 494 | 3 430 674 | |
2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −320 | 180 404 | −0,18 | 67,90 | −21 727 | 12 248 800 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −42 863 | 8 201 569 | −0,52 | 68,72 | −2 945 370 | 563 578 195 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 581 | 1 300 894 | −0,50 | 68,72 | −452 219 | 89 392 102 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 134 | 256 771 | −0,44 | 68,72 | −77 924 | 17 644 250 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −658 | 166 148 | −0,39 | 68,72 | −45 215 | 11 417 009 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −50 | 50 550 | −0,10 | 68,72 | −3 436 | 3 473 589 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −734 | 180 724 | −0,40 | 68,72 | −50 437 | 12 418 612 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −21 116 | 8 244 432 | −0,26 | 68,63 | −1 449 147 | 565 798 055 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 242 | 1 307 475 | −0,25 | 68,63 | −222 492 | 89 729 264 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −559 | 257 905 | −0,22 | 68,63 | −38 363 | 17 699 479 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −324 | 166 806 | −0,19 | 68,63 | −22 235 | 11 447 545 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −25 | 50 600 | −0,05 | 68,63 | −1 716 | 3 472 572 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −362 | 181 458 | −0,20 | 68,63 | −24 843 | 12 453 081 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −66 784 | 8 265 548 | −0,80 | 66,64 | −4 450 459 | 550 812 813 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −10 253 | 1 310 717 | −0,78 | 66,64 | −683 256 | 87 345 657 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 768 | 258 464 | −0,68 | 66,64 | −117 819 | 17 223 938 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 025 | 167 130 | −0,61 | 66,64 | −68 306 | 11 137 476 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −78 | 50 625 | −0,15 | 66,64 | −5 198 | 3 373 630 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 145 | 181 820 | −0,63 | 66,64 | −76 302 | 12 116 412 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −80 146 | 8 332 332 | −0,95 | 68,90 | −5 521 963 | 574 087 676 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −12 305 | 1 320 970 | −0,92 | 68,90 | −847 800 | 91 013 248 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 121 | 260 232 | −0,81 | 68,90 | −146 134 | 17 929 673 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 230 | 168 155 | −0,73 | 68,90 | −84 746 | 11 585 678 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −93 | 50 703 | −0,18 | 68,90 | −6 408 | 3 493 376 | |
2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 374 | 182 965 | −0,75 | 68,90 | −94 667 | 12 606 069 | |
2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4 161 | 89 233 | 4,89 | 2,59 | 10 777 | 231 113 | |
2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4 161 | 89 233 | 4,89 | 2,59 | 10 777 | 231 113 | |
2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4 161 | 4 288 031 | 0,10 | 2,59 | 10 777 | 11 106 000 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8 412 478 | 0,00 | 66,84 | 19 918 | 562 290 030 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8 412 478 | 0,00 | 66,84 | 19 918 | 562 290 030 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 1 507 172 | 0,02 | 66,84 | 19 918 | 100 739 376 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 436 250 | 0,07 | 66,84 | 19 918 | 29 158 950 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 343 282 | 0,09 | 66,84 | 19 918 | 22 944 969 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 224 693 | 0,13 | 66,84 | 19 918 | 15 018 480 | |
2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811 082 | 0,03 | 86,01 | 18 922 | 69 761 163 | |
2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811 082 | 0,03 | 86,01 | 18 922 | 69 761 163 | |
2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811 082 | 0,03 | 86,01 | 18 922 | 69 761 163 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −46 678 | 8 412 180 | −0,55 | 74,71 | −3 487 122 | 628 439 478 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −7 167 | 1 332 977 | −0,53 | 74,71 | −535 417 | 99 581 246 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 235 | 262 055 | −0,47 | 74,71 | −92 262 | 19 577 055 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −716 | 169 087 | −0,42 | 74,71 | −53 489 | 12 631 797 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −55 | 50 498 | −0,11 | 74,71 | −4 109 | 3 772 499 | |
2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −800 | 184 041 | −0,43 | 74,71 | −59 765 | 13 748 949 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −41 281 | 8 458 858 | −0,49 | 74,34 | −3 068 962 | 628 858 572 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 338 | 1 340 144 | −0,47 | 74,34 | −471 187 | 99 630 593 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 092 | 263 290 | −0,41 | 74,34 | −81 183 | 19 573 821 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −634 | 169 803 | −0,37 | 74,34 | −47 134 | 12 623 698 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −48 | 50 553 | −0,09 | 74,34 | −3 568 | 3 758 272 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −707 | 184 841 | −0,38 | 74,34 | −52 561 | 13 741 671 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −86 620 | 8 500 139 | −1,01 | 74,63 | −6 464 529 | 634 373 024 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −13 298 | 1 346 482 | −0,98 | 74,63 | −992 442 | 100 489 163 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 293 | 264 382 | −0,86 | 74,63 | −171 129 | 19 731 067 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 329 | 170 437 | −0,77 | 74,63 | −99 184 | 12 719 867 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −101 | 50 601 | −0,20 | 74,63 | −7 538 | 3 776 398 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 485 | 185 548 | −0,79 | 74,63 | −110 827 | 13 847 614 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −90 251 | 8 586 759 | −1,04 | 74,19 | −6 695 487 | 637 029 325 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −13 856 | 1 359 780 | −1,01 | 74,19 | −1 027 941 | 100 878 543 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 388 | 266 675 | −0,89 | 74,19 | −177 160 | 19 783 925 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 385 | 171 766 | −0,80 | 74,19 | −102 750 | 12 742 873 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −106 | 50 702 | −0,21 | 74,19 | −7 864 | 3 761 450 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 547 | 187 033 | −0,82 | 74,19 | −114 768 | 13 875 492 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −413 | 8 677 010 | 0,00 | 74,56 | −30 795 | 647 001 251 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −63 | 1 373 636 | 0,00 | 74,56 | −4 698 | 102 425 168 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 | 269 063 | 0,00 | 74,56 | −820 | 20 062 683 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 | 173 151 | 0,00 | 74,56 | −447 | 12 911 004 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −7 | 188 580 | 0,00 | 74,56 | −522 | 14 061 468 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −42 124 | 8 677 423 | −0,48 | 74,50 | −3 138 238 | 646 468 014 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 467 | 1 373 699 | −0,47 | 74,50 | −481 792 | 102 340 576 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 115 | 269 074 | −0,41 | 74,50 | −83 068 | 20 046 013 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −647 | 173 157 | −0,37 | 74,50 | −48 202 | 12 900 196 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −49 | 50 808 | −0,10 | 74,50 | −3 650 | 3 785 196 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −722 | 188 587 | −0,38 | 74,50 | −53 789 | 14 049 732 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 068 | 8 719 547 | −0,04 | 76,57 | −234 915 | 667 649 610 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −471 | 1 380 166 | −0,03 | 76,57 | −36 064 | 105 678 345 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −81 | 270 189 | −0,03 | 76,57 | −6 202 | 20 688 183 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −47 | 173 804 | −0,03 | 76,57 | −3 599 | 13 308 051 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 | 50 857 | −0,01 | 76,57 | −306 | 3 894 085 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −52 | 189 309 | −0,03 | 76,57 | −3 982 | 14 495 258 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −41 281 | 8 458 858 | −0,49 | 74,34 | −3 068 962 | 628 858 572 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 338 | 1 340 144 | −0,47 | 74,34 | −471 187 | 99 630 593 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 092 | 263 290 | −0,41 | 74,34 | −81 183 | 19 573 821 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −634 | 169 803 | −0,37 | 74,34 | −47 134 | 12 623 698 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −48 | 50 553 | −0,09 | 74,34 | −3 568 | 3 758 272 | |
2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −707 | 184 841 | −0,38 | 74,34 | −52 561 | 13 741 671 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 648 | 8 722 615 | −0,02 | 76,03 | −125 301 | 663 197 864 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −253 | 1 380 637 | −0,02 | 76,03 | −19 236 | 104 972 592 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −44 | 270 270 | −0,02 | 76,03 | −3 345 | 20 549 169 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −25 | 173 851 | −0,01 | 76,03 | −1 901 | 13 218 239 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 | 50 861 | 0,00 | 76,03 | −152 | 3 867 064 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −28 | 189 361 | −0,01 | 76,03 | −2 129 | 14 397 496 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −51 987 | 8 724 263 | −0,59 | 76,50 | −3 977 031 | 667 410 482 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −7 982 | 1 380 890 | −0,57 | 76,50 | −610 627 | 105 638 775 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 375 | 270 314 | −0,51 | 76,50 | −105 188 | 20 679 156 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −798 | 173 876 | −0,46 | 76,50 | −61 047 | 13 301 601 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −61 | 50 863 | −0,12 | 76,50 | −4 667 | 3 891 045 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −891 | 189 389 | −0,47 | 76,50 | −68 162 | 14 488 353 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −247 | 8 776 250 | 0,00 | 75,40 | −18 624 | 661 729 250 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −39 | 1 388 872 | 0,00 | 75,40 | −2 941 | 104 720 949 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −7 | 271 689 | 0,00 | 75,40 | −528 | 20 485 351 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 | 174 674 | 0,00 | 75,40 | −302 | 13 170 420 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 | 174 674 | 0,00 | 75,40 | −302 | 13 170 420 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 | 50 924 | 0,00 | 75,40 | −75 | 3 839 670 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −63 047 | 8 776 497 | −0,71 | 75,92 | −4 786 390 | 666 292 344 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 679 | 1 388 911 | −0,69 | 75,92 | −734 808 | 105 443 068 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 668 | 271 696 | −0,61 | 75,92 | −126 631 | 20 626 563 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −967 | 174 678 | −0,55 | 75,92 | −73 413 | 13 261 169 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −73 | 50 925 | −0,14 | 75,92 | −5 542 | 3 866 114 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 080 | 190 284 | −0,56 | 75,92 | −81 991 | 14 445 943 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 832 | 8 839 544 | −0,03 | 76,05 | −215 369 | 672 232 294 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −435 | 1 398 590 | −0,03 | 76,05 | −33 081 | 106 360 392 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −75 | 273 364 | −0,03 | 76,05 | −5 704 | 20 788 867 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −43 | 175 645 | −0,02 | 76,05 | −3 270 | 13 357 504 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 | 50 998 | −0,01 | 76,05 | −228 | 3 878 311 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −49 | 191 364 | −0,03 | 76,05 | −3 726 | 14 552 907 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −61 122 | 8 842 376 | −0,69 | 75,63 | −4 622 669 | 668 750 665 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 384 | 1 399 025 | −0,67 | 75,63 | −709 714 | 105 808 541 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 618 | 273 439 | −0,59 | 75,63 | −122 370 | 20 680 246 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −938 | 175 688 | −0,53 | 75,63 | −70 941 | 13 287 319 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −71 | 51 001 | −0,14 | 75,63 | −5 370 | 3 857 216 | |
2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 047 | 191 413 | −0,54 | 75,63 | −79 185 | 14 476 603 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 296 | 8 903 498 | −0,04 | 74,03 | −244 007 | 659 137 531 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −506 | 1 408 409 | −0,04 | 74,03 | −37 460 | 104 266 349 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −87 | 275 057 | −0,03 | 74,03 | −6 441 | 20 362 827 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −51 | 176 626 | −0,03 | 74,03 | −3 776 | 13 075 852 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 | 51 072 | −0,01 | 74,03 | −296 | 3 780 927 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −56 | 192 460 | −0,03 | 74,03 | −4 146 | 14 248 064 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −37 107 | 8 906 794 | −0,41 | 75,08 | −2 786 101 | 668 747 923 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −5 697 | 1 408 915 | −0,40 | 75,08 | −427 747 | 105 785 424 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −982 | 275 144 | −0,36 | 75,08 | −73 731 | 20 658 609 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −569 | 176 677 | −0,32 | 75,08 | −42 722 | 13 265 422 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −43 | 51 076 | −0,08 | 75,08 | −3 229 | 3 834 934 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −637 | 192 516 | −0,33 | 75,08 | −47 828 | 14 454 660 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −18 703 | 8 943 901 | −0,21 | 73,55 | −1 375 551 | 657 797 981 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 872 | 1 414 612 | −0,20 | 73,55 | −211 227 | 104 040 610 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −495 | 276 126 | −0,18 | 73,55 | −36 406 | 20 308 267 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −287 | 177 246 | −0,16 | 73,55 | −21 108 | 13 035 929 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −22 | 51 119 | −0,04 | 73,55 | −1 618 | 3 759 654 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −321 | 193 153 | −0,17 | 73,55 | −23 609 | 14 205 843 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 647 | 8 962 604 | −0,02 | 73,72 | −121 421 | 660 745 573 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −253 | 1 417 484 | −0,02 | 73,72 | −18 652 | 104 500 464 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −44 | 276 621 | −0,02 | 73,72 | −3 244 | 20 393 192 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −25 | 177 533 | −0,01 | 73,72 | −1 843 | 13 088 177 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 | 51 141 | 0,00 | 73,72 | −147 | 3 770 242 | |
2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −29 | 193 474 | −0,01 | 73,72 | −2 138 | 14 263 387 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 486 | 8 964 251 | −0,09 | 77,04 | −653 755 | 690 598 726 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 303 | 1 417 737 | −0,09 | 77,04 | −100 382 | 109 221 324 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −225 | 276 665 | −0,08 | 77,04 | −17 334 | 21 314 050 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −130 | 177 558 | −0,07 | 77,04 | −10 015 | 13 678 926 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −10 | 51 143 | −0,02 | 77,04 | −770 | 3 940 016 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −146 | 193 503 | −0,08 | 77,04 | −11 248 | 14 907 316 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −22 914 | 8 972 737 | −0,25 | 76,49 | −1 752 680 | 686 320 167 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 518 | 1 419 040 | −0,25 | 76,49 | −269 090 | 108 541 660 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −607 | 276 890 | −0,22 | 76,49 | −46 429 | 21 179 178 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −352 | 177 688 | −0,20 | 76,49 | −26 924 | 13 591 266 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −27 | 51 153 | −0,05 | 76,49 | −2 065 | 3 912 667 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −393 | 193 649 | −0,20 | 76,49 | −30 060 | 14 812 115 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −58 412 | 8 995 651 | −0,65 | 77,15 | −4 506 626 | 694 036 064 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 968 | 1 422 558 | −0,63 | 77,15 | −691 903 | 109 753 764 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 546 | 277 497 | −0,55 | 77,15 | −119 278 | 21 409 560 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −896 | 178 040 | −0,50 | 77,15 | −69 129 | 13 736 213 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −68 | 51 180 | −0,13 | 77,15 | −5 246 | 3 948 660 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 001 | 194 042 | −0,51 | 77,15 | −77 230 | 14 970 806 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 909 | 9 054 063 | −0,08 | 77,64 | −536 386 | 702 919 424 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 060 | 1 431 526 | −0,07 | 77,64 | −82 294 | 111 137 666 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −183 | 279 043 | −0,07 | 77,64 | −14 207 | 21 663 727 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −107 | 178 936 | −0,06 | 77,64 | −8 307 | 13 891 840 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 | 51 248 | −0,02 | 77,64 | −621 | 3 978 679 | |
2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −118 | 195 043 | −0,06 | 77,64 | −9 161 | 15 142 319 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −493 | 9 060 972 | −0,01 | 76,20 | −37 565 | 690 423 414 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −76 | 1 432 586 | −0,01 | 76,20 | −5 791 | 109 159 472 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −13 | 279 226 | 0,00 | 76,20 | −991 | 21 276 323 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 | 179 043 | 0,00 | 76,20 | −610 | 13 642 629 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 | 51 256 | 0,00 | 76,20 | −76 | 3 905 579 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 | 195 161 | 0,00 | 76,20 | −686 | 14 870 780 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −742 | 9 061 465 | −0,01 | 76,20 | −56 540 | 690 483 633 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −114 | 1 432 662 | −0,01 | 76,20 | −8 687 | 109 168 844 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −20 | 279 239 | −0,01 | 76,20 | −1 524 | 21 278 012 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 | 179 051 | −0,01 | 76,20 | −838 | 13 643 686 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 | 51 257 | 0,00 | 76,20 | −76 | 3 905 783 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −13 | 195 170 | −0,01 | 76,20 | −991 | 14 871 954 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −31 482 | 9 062 207 | −0,35 | 76,66 | −2 413 501 | 694 735 069 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 833 | 1 432 776 | −0,34 | 76,66 | −370 512 | 109 840 763 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −833 | 279 259 | −0,30 | 76,66 | −63 860 | 21 408 805 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −484 | 179 062 | −0,27 | 76,66 | −37 105 | 13 727 412 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −37 | 51 258 | −0,07 | 76,66 | −2 837 | 3 929 587 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −539 | 195 183 | −0,28 | 76,66 | −41 321 | 14 963 295 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −620 | 9 093 689 | −0,01 | 77,81 | −48 239 | 707 539 019 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −95 | 1 437 609 | −0,01 | 77,81 | −7 392 | 111 853 887 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −16 | 280 092 | −0,01 | 77,81 | −1 245 | 21 792 698 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −10 | 179 546 | −0,01 | 77,81 | −778 | 13 969 666 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 | 51 295 | 0,00 | 77,81 | −78 | 3 991 033 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 | 195 722 | −0,01 | 77,81 | −856 | 15 228 248 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 506 | 9 094 309 | −0,07 | 78,13 | −508 342 | 710 577 468 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −999 | 1 437 704 | −0,07 | 78,13 | −78 056 | 112 333 996 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −172 | 280 108 | −0,06 | 78,13 | −13 439 | 21 886 043 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −100 | 179 556 | −0,06 | 78,13 | −7 813 | 14 029 482 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 | 51 296 | −0,02 | 78,13 | −625 | 4 007 977 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −112 | 195 733 | −0,06 | 78,13 | −8 751 | 15 293 461 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 9 100 815 | 0,09 | 17,59 | 145 118 | 160 083 336 | |
2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 9 100 815 | 0,09 | 17,59 | 145 118 | 160 083 336 | |
2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 29 288 793 | 0,07 | 2,80 | 56 000 | 82 008 620 | |
2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 29 288 793 | 0,07 | 2,80 | 56 000 | 82 008 620 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −13 634 | 9 092 565 | −0,15 | 70,55 | −961 887 | 641 485 916 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 093 | 1 430 453 | −0,15 | 70,55 | −147 662 | 100 919 317 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −361 | 280 280 | −0,13 | 70,55 | −25 469 | 19 773 922 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −210 | 179 656 | −0,12 | 70,55 | −14 816 | 12 674 839 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −16 | 51 304 | −0,03 | 70,55 | −1 129 | 3 619 528 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −234 | 195 845 | −0,12 | 70,55 | −16 509 | 13 816 982 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −24 660 | 9 106 199 | −0,27 | 71,35 | −1 759 553 | 649 750 064 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 786 | 1 432 546 | −0,26 | 71,35 | −270 141 | 102 215 738 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −653 | 280 641 | −0,23 | 71,35 | −46 593 | 20 024 437 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −378 | 179 866 | −0,21 | 71,35 | −26 971 | 12 833 889 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −29 | 51 320 | −0,06 | 71,35 | −2 069 | 3 661 810 | |
2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −423 | 196 079 | −0,22 | 71,35 | −30 182 | 13 990 727 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −75 736 | 9 130 859 | −0,82 | 72,20 | −5 468 397 | 659 279 065 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 627 | 1 436 332 | −0,80 | 72,20 | −839 509 | 103 708 054 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 004 | 281 294 | −0,71 | 72,20 | −144 696 | 20 310 383 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 162 | 180 244 | −0,64 | 72,20 | −83 900 | 13 014 230 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −89 | 51 349 | −0,17 | 72,20 | −6 426 | 3 707 572 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 298 | 196 502 | −0,66 | 72,20 | −93 720 | 14 188 113 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −65 426 | 9 206 595 | −0,71 | 72,02 | −4 711 967 | 663 057 131 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −10 044 | 1 447 959 | −0,69 | 72,02 | −723 367 | 104 281 718 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 732 | 283 298 | −0,61 | 72,02 | −124 738 | 20 403 065 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 004 | 181 406 | −0,55 | 72,02 | −72 308 | 13 064 824 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −76 | 51 438 | −0,15 | 72,02 | −5 474 | 3 704 554 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 121 | 197 800 | −0,56 | 72,02 | −80 734 | 14 245 516 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 648 | 9 272 021 | −0,02 | 73,46 | −121 054 | 681 076 303 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −253 | 1 458 003 | −0,02 | 73,46 | −18 584 | 107 097 610 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −44 | 285 030 | −0,02 | 73,46 | −3 232 | 20 936 879 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −25 | 182 410 | −0,01 | 73,46 | −1 836 | 13 398 927 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 | 51 514 | 0,00 | 73,46 | −147 | 3 783 961 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −28 | 198 921 | −0,01 | 73,46 | −2 057 | 14 611 742 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −29 260 | 9 273 669 | −0,31 | 70,52 | −2 063 313 | 653 946 680 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 492 | 1 458 256 | −0,31 | 70,52 | −316 760 | 102 831 109 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −774 | 285 074 | −0,27 | 70,52 | −54 580 | 20 102 421 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −450 | 182 435 | −0,25 | 70,52 | −31 732 | 12 864 678 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −34 | 51 516 | −0,07 | 70,52 | −2 398 | 3 632 728 | |
2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −502 | 198 949 | −0,25 | 70,52 | −35 399 | 14 029 187 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −42 521 | 9 302 929 | −0,45 | 71,00 | −3 018 995 | 660 508 889 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 529 | 1 462 748 | −0,44 | 71,00 | −463 560 | 103 855 254 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 125 | 285 848 | −0,39 | 71,00 | −79 875 | 20 295 237 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −652 | 182 885 | −0,36 | 71,00 | −46 292 | 12 984 853 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −50 | 51 550 | −0,10 | 71,00 | −3 550 | 3 660 055 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −729 | 199 451 | −0,36 | 71,00 | −51 759 | 14 161 041 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −10 547 | 9 345 450 | −0,11 | 71,61 | −755 298 | 669 251 973 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 619 | 1 469 277 | −0,11 | 71,61 | −115 941 | 105 218 746 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −279 | 286 973 | −0,10 | 71,61 | −19 980 | 20 550 883 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −162 | 183 537 | −0,09 | 71,61 | −11 601 | 13 143 562 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −12 | 51 600 | −0,02 | 71,61 | −859 | 3 695 210 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −181 | 200 180 | −0,09 | 71,61 | −12 962 | 14 335 410 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −13 595 | 9 355 997 | −0,15 | 72,23 | −981 964 | 675 781 792 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 087 | 1 470 896 | −0,14 | 72,23 | −150 744 | 106 242 524 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −360 | 287 252 | −0,13 | 72,23 | −26 003 | 20 748 155 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −209 | 183 699 | −0,11 | 72,23 | −15 096 | 13 268 542 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −16 | 51 612 | −0,03 | 72,23 | −1 156 | 3 727 924 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −233 | 200 361 | −0,12 | 72,23 | −16 830 | 14 472 035 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −132 363 | 9 369 592 | −1,39 | 72,79 | −9 634 226 | 681 978 871 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −20 322 | 1 472 983 | −1,36 | 72,79 | −1 479 165 | 107 213 130 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 503 | 287 612 | −1,20 | 72,79 | −254 971 | 20 934 242 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 031 | 183 908 | −1,09 | 72,79 | −147 829 | 13 386 001 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −155 | 51 628 | −0,30 | 72,79 | −11 282 | 3 757 816 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 268 | 200 594 | −1,12 | 72,79 | −165 080 | 14 600 515 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −149 754 | 9 501 955 | −1,55 | 70,79 | −10 601 295 | 672 656 697 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −22 991 | 1 493 305 | −1,52 | 70,79 | −1 627 565 | 105 713 152 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 963 | 291 115 | −1,34 | 70,79 | −280 546 | 20 608 438 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 298 | 185 939 | −1,22 | 70,79 | −162 679 | 13 162 882 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −175 | 51 783 | −0,34 | 70,79 | −12 388 | 3 665 791 | |
2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 566 | 202 862 | −1,25 | 70,79 | −181 651 | 14 360 885 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −493 | 9 651 709 | −0,01 | 70,07 | −34 545 | 676 311 658 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −76 | 1 516 296 | −0,01 | 70,07 | −5 325 | 106 249 438 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −13 | 295 078 | 0,00 | 70,07 | −911 | 20 676 617 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 | 188 237 | 0,00 | 70,07 | −561 | 13 190 087 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 | 51 958 | 0,00 | 70,07 | −70 | 3 640 785 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 | 205 428 | 0,00 | 70,07 | −631 | 14 394 689 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −23 462 | 9 652 202 | −0,24 | 70,22 | −1 647 574 | 677 807 546 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 602 | 1 516 372 | −0,24 | 70,22 | −252 944 | 106 484 343 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −621 | 295 091 | −0,21 | 70,22 | −43 609 | 20 722 205 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −360 | 188 245 | −0,19 | 70,22 | −25 280 | 13 219 147 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −27 | 51 959 | −0,05 | 70,22 | −1 896 | 3 648 722 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −402 | 205 437 | −0,20 | 70,22 | −28 230 | 14 426 423 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 392 | 9 675 664 | −0,09 | 70,28 | −589 772 | 679 985 347 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 288 | 1 519 974 | −0,08 | 70,28 | −90 518 | 106 820 581 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −222 | 295 712 | −0,08 | 70,28 | −15 602 | 20 782 018 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −129 | 188 605 | −0,07 | 70,28 | −9 066 | 13 254 763 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −10 | 51 986 | −0,02 | 70,28 | −703 | 3 653 467 | |
2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −144 | 205 839 | −0,07 | 70,28 | −10 120 | 14 465 933 | |
2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 658 | 85 072 | 4,49 | 3,52 | 12 876 | 299 453 | |
2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 658 | 85 072 | 4,49 | 3,52 | 12 876 | 299 453 | |
2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 658 | 85 072 | 4,49 | 3,52 | 12 876 | 299 453 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295 934 | 0,10 | 64,41 | 19 967 | 19 061 109 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295 934 | 0,10 | 64,41 | 19 967 | 19 061 109 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295 934 | 0,10 | 64,41 | 19 967 | 19 061 109 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 1 695 159 | 0,02 | 64,41 | 19 967 | 109 185 191 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 225 893 | 0,14 | 64,41 | 19 967 | 14 549 768 | |
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 362 631 | 0,09 | 64,41 | 19 967 | 23 357 063 | |
2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810 862 | 0,04 | 63,59 | 18 950 | 51 562 715 | |
2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810 862 | 0,04 | 63,59 | 18 950 | 51 562 715 | |
2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 29 421 884 | 0,00 | 63,59 | 18 950 | 1 870 937 604 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −15 243 | 9 683 746 | −0,16 | 73,09 | −1 114 047 | 707 744 323 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 340 | 1 520 952 | −0,15 | 73,09 | −171 021 | 111 159 994 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −403 | 295 624 | −0,14 | 73,09 | −29 454 | 21 605 917 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −234 | 188 424 | −0,12 | 73,09 | −17 102 | 13 771 119 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −18 | 51 686 | −0,03 | 73,09 | −1 316 | 3 777 513 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −262 | 205 673 | −0,13 | 73,09 | −19 148 | 15 031 776 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −12 627 | 9 698 989 | −0,13 | 71,81 | −906 797 | 696 524 166 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 939 | 1 523 292 | −0,13 | 71,81 | −139 248 | 109 393 844 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −334 | 296 027 | −0,11 | 71,81 | −23 986 | 21 258 913 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −194 | 188 658 | −0,10 | 71,81 | −13 932 | 13 548 304 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −15 | 51 704 | −0,03 | 71,81 | −1 077 | 3 713 076 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −216 | 205 935 | −0,10 | 71,81 | −15 512 | 14 789 037 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −34 794 | 9 711 616 | −0,36 | 74,88 | −2 605 510 | 727 243 681 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −5 342 | 1 525 231 | −0,35 | 74,88 | −400 030 | 114 215 246 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −921 | 296 361 | −0,31 | 74,88 | −68 968 | 22 192 667 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −534 | 188 852 | −0,28 | 74,88 | −39 988 | 14 141 974 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −41 | 51 719 | −0,08 | 74,88 | −3 070 | 3 872 920 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −597 | 206 151 | −0,29 | 74,88 | −44 706 | 15 437 391 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −7 718 | 9 746 410 | −0,08 | 73,83 | −569 813 | 719 568 679 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 185 | 1 530 573 | −0,08 | 73,83 | −87 487 | 113 000 827 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −204 | 297 282 | −0,07 | 73,83 | −15 061 | 21 948 063 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −118 | 189 386 | −0,06 | 73,83 | −8 712 | 13 982 198 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 | 51 760 | −0,02 | 73,83 | −664 | 3 821 394 | |
2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −132 | 206 748 | −0,06 | 73,83 | −9 745 | 15 264 019 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −84 418 | 9 754 128 | −0,86 | 76,15 | −6 428 768 | 742 815 864 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −12 961 | 1 531 758 | −0,84 | 76,15 | −987 032 | 116 649 499 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 234 | 297 486 | −0,75 | 76,15 | −170 128 | 22 654 749 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 296 | 189 504 | −0,68 | 76,15 | −98 696 | 14 431 488 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −99 | 51 769 | −0,19 | 76,15 | −7 539 | 3 942 416 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 447 | 206 880 | −0,69 | 76,15 | −110 195 | 15 754 740 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −76 364 | 9 838 546 | −0,77 | 75,46 | −5 762 481 | 742 423 568 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 724 | 1 544 719 | −0,75 | 75,46 | −884 701 | 116 565 577 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 021 | 299 720 | −0,67 | 75,46 | −152 506 | 22 617 081 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 172 | 190 800 | −0,61 | 75,46 | −88 440 | 14 397 902 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −89 | 51 868 | −0,17 | 75,46 | −6 716 | 3 913 996 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 309 | 208 327 | −0,62 | 75,46 | −98 778 | 15 720 501 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 538 | 9 914 910 | −0,03 | 77,75 | −197 318 | 770 839 635 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −390 | 1 556 443 | −0,03 | 77,75 | −30 321 | 121 006 439 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −67 | 301 741 | −0,02 | 77,75 | −5 209 | 23 459 005 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −39 | 191 972 | −0,02 | 77,75 | −3 032 | 14 924 959 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 | 51 957 | −0,01 | 77,75 | −233 | 4 039 423 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −43 | 209 636 | −0,02 | 77,75 | −3 343 | 16 298 256 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −5 493 | 9 917 448 | −0,06 | 73,81 | −405 449 | 732 025 680 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −843 | 1 556 833 | −0,05 | 73,81 | −62 223 | 114 912 802 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −146 | 301 808 | −0,05 | 73,81 | −10 777 | 22 277 022 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −84 | 192 011 | −0,04 | 73,81 | −6 200 | 14 172 697 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 | 51 960 | −0,01 | 73,81 | −443 | 3 835 266 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −95 | 209 679 | −0,05 | 73,81 | −7 012 | 15 476 805 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −18 604 | 9 922 941 | −0,19 | 75,83 | −1 410 758 | 752 465 547 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 856 | 1 557 676 | −0,18 | 75,83 | −216 573 | 118 119 973 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −492 | 301 954 | −0,16 | 75,83 | −37 309 | 22 897 444 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −286 | 192 095 | −0,15 | 75,83 | −21 688 | 14 566 737 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −21 | 51 966 | −0,04 | 75,83 | −1 592 | 3 940 629 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −319 | 209 774 | −0,15 | 75,83 | −24 190 | 15 907 351 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −371 | 9 941 545 | 0,00 | 77,11 | −28 608 | 766 592 535 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −57 | 1 560 532 | 0,00 | 77,11 | −4 395 | 120 332 623 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −10 | 302 446 | 0,00 | 77,11 | −771 | 23 321 611 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 | 192 381 | 0,00 | 77,11 | −463 | 14 834 499 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 | 192 381 | 0,00 | 77,11 | −463 | 14 834 499 | |
2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 | 51 987 | 0,00 | 77,11 | −77 | 4 008 718 | |
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1 569 | 1 569 | |||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1 569 | 1 569 | |||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | −10 731 | 0 | −100,00 | ||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71 647 | 71 647 | |||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71 647 | 71 647 | |||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | −489 977 | 0 | −100,00 | ||||
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11 178 823 | 35 976 940 | 45,08 | 17,00 | 190 039 991 | 611 607 980 | |
2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 585 882 | 3 736 902 | 18,59 | 17,00 | 9 959 994 | 63 527 334 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −247 | 9 941 916 | 0,00 | 76,62 | −18 925 | 761 724 749 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −38 | 1 560 589 | 0,00 | 76,62 | −2 911 | 119 568 428 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 | 302 456 | 0,00 | 76,62 | −460 | 23 173 423 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 | 192 387 | 0,00 | 76,62 | −306 | 14 740 211 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 | 192 387 | 0,00 | 76,62 | −306 | 14 740 211 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 | 51 988 | 0,00 | 76,62 | −77 | 3 983 191 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −32 598 | 9 942 163 | −0,33 | 77,52 | −2 527 147 | 770 762 210 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −5 005 | 1 560 627 | −0,32 | 77,52 | −388 011 | 120 986 984 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −863 | 302 462 | −0,28 | 77,52 | −66 904 | 23 448 246 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −500 | 192 391 | −0,26 | 77,52 | −38 762 | 14 915 035 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −38 | 51 989 | −0,07 | 77,52 | −2 946 | 4 030 426 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −559 | 210 103 | −0,27 | 77,52 | −43 336 | 16 288 151 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −89 047 | 9 974 761 | −0,88 | 78,05 | −6 950 074 | 778 525 109 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −13 671 | 1 565 632 | −0,87 | 78,05 | −1 067 015 | 122 196 795 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 357 | 303 325 | −0,77 | 78,05 | −183 963 | 23 674 365 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 367 | 192 891 | −0,70 | 78,05 | −106 694 | 15 055 046 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −104 | 52 027 | −0,20 | 78,05 | −8 117 | 4 060 681 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 526 | 210 662 | −0,72 | 78,05 | −119 104 | 16 442 064 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −44 659 | 10 063 808 | −0,44 | 80,09 | −3 576 721 | 806 006 357 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 856 | 1 579 303 | −0,43 | 80,09 | −549 094 | 126 485 746 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 182 | 305 682 | −0,39 | 80,09 | −94 666 | 24 481 949 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −685 | 194 258 | −0,35 | 80,09 | −54 861 | 15 558 046 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −52 | 52 131 | −0,10 | 80,09 | −4 165 | 4 175 151 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −765 | 212 188 | −0,36 | 80,09 | −61 269 | 16 994 052 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −129 121 | 10 108 467 | −1,26 | 79,07 | −10 209 675 | 799 282 551 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −19 824 | 1 586 159 | −1,23 | 79,07 | −1 567 496 | 125 418 544 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 417 | 306 864 | −1,10 | 79,07 | −270 184 | 24 263 921 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 981 | 194 943 | −1,01 | 79,07 | −156 639 | 15 414 260 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −151 | 52 183 | −0,29 | 79,07 | −11 940 | 4 126 141 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 214 | 212 953 | −1,03 | 79,07 | −175 062 | 16 838 321 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −39 591 | 10 237 588 | −0,39 | 79,63 | −3 152 536 | 815 194 562 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −6 078 | 1 605 983 | −0,38 | 79,63 | −483 977 | 127 880 572 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 048 | 310 281 | −0,34 | 79,63 | −83 450 | 24 706 931 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −608 | 196 924 | −0,31 | 79,63 | −48 414 | 15 680 586 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −46 | 52 334 | −0,09 | 79,63 | −3 663 | 4 167 231 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −678 | 215 167 | −0,31 | 79,63 | −53 988 | 17 133 232 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −30 257 | 10 277 179 | −0,29 | 77,61 | −2 348 376 | 797 656 054 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 646 | 1 612 061 | −0,29 | 77,61 | −360 596 | 125 118 986 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −801 | 311 329 | −0,26 | 77,61 | −62 169 | 24 163 582 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −465 | 197 532 | −0,23 | 77,61 | −36 091 | 15 331 308 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −35 | 52 380 | −0,07 | 77,61 | −2 717 | 4 065 437 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −518 | 215 845 | −0,24 | 77,61 | −40 204 | 16 752 659 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 994 | 10 307 436 | −0,12 | 78,80 | −945 149 | 812 244 510 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 841 | 1 616 707 | −0,11 | 78,80 | −145 074 | 127 399 422 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −317 | 312 130 | −0,10 | 78,80 | −24 980 | 24 596 406 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −184 | 197 997 | −0,09 | 78,80 | −14 500 | 15 602 520 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −14 | 52 415 | −0,03 | 78,80 | −1 103 | 4 130 396 | |
2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −206 | 216 363 | −0,10 | 78,80 | −16 233 | 17 049 794 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −77 976 | 10 319 430 | −0,75 | 76,81 | −5 989 017 | 792 593 109 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 972 | 1 618 548 | −0,73 | 76,81 | −919 520 | 124 314 036 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 064 | 312 447 | −0,66 | 76,81 | −158 527 | 23 997 773 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 197 | 198 181 | −0,60 | 76,81 | −91 937 | 15 221 470 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −91 | 52 429 | −0,17 | 76,81 | −6 989 | 4 026 857 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 335 | 216 569 | −0,61 | 76,81 | −102 536 | 16 633 777 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −13 595 | 10 397 406 | −0,13 | 74,01 | −1 006 150 | 769 499 541 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 087 | 1 630 520 | −0,13 | 74,01 | −154 456 | 120 672 829 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −360 | 314 511 | −0,11 | 74,01 | −26 643 | 23 276 582 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −209 | 199 378 | −0,10 | 74,01 | −15 468 | 14 755 727 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −16 | 52 520 | −0,03 | 74,01 | −1 184 | 3 886 942 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −233 | 217 904 | −0,11 | 74,01 | −17 244 | 16 126 814 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −57 979 | 10 411 001 | −0,55 | 74,71 | −4 331 524 | 777 790 268 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 901 | 1 632 607 | −0,54 | 74,71 | −664 980 | 121 969 620 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 534 | 314 871 | −0,48 | 74,71 | −114 603 | 23 523 540 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −890 | 199 587 | −0,44 | 74,71 | −66 491 | 14 910 845 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −68 | 52 536 | −0,13 | 74,71 | −5 080 | 3 924 886 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −994 | 218 137 | −0,45 | 74,71 | −74 260 | 16 296 688 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −56 764 | 10 468 980 | −0,54 | 75,27 | −4 272 831 | 788 037 813 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 715 | 1 641 508 | −0,53 | 75,27 | −656 009 | 123 562 217 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 502 | 316 405 | −0,47 | 75,27 | −113 061 | 23 816 943 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −871 | 200 477 | −0,43 | 75,27 | −65 563 | 15 090 626 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −66 | 52 604 | −0,13 | 75,27 | −4 968 | 3 959 692 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −973 | 219 131 | −0,44 | 75,27 | −73 241 | 16 494 779 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −36 652 | 10 525 744 | −0,35 | 73,76 | −2 703 294 | 776 333 617 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −5 627 | 1 650 223 | −0,34 | 73,76 | −415 023 | 121 713 353 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −970 | 317 907 | −0,30 | 73,76 | −71 543 | 23 447 453 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −563 | 201 348 | −0,28 | 73,76 | −41 524 | 14 850 563 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −43 | 52 670 | −0,08 | 73,76 | −3 171 | 3 884 713 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −628 | 220 104 | −0,28 | 73,76 | −46 319 | 16 233 925 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −77 558 | 10 562 396 | −0,73 | 74,24 | −5 758 092 | 784 177 629 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 907 | 1 655 850 | −0,71 | 74,24 | −884 004 | 122 934 278 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 052 | 318 877 | −0,64 | 74,24 | −152 345 | 23 674 194 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 190 | 201 911 | −0,59 | 74,24 | −88 348 | 14 990 357 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −91 | 52 713 | −0,17 | 74,24 | −6 756 | 3 913 540 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 329 | 220 732 | −0,60 | 74,24 | −98 668 | 16 387 673 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 204 | 10 639 954 | −0,08 | 74,05 | −607 484 | 787 859 866 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 260 | 1 667 757 | −0,08 | 74,05 | −93 300 | 123 492 903 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −217 | 320 929 | −0,07 | 74,05 | −16 068 | 23 763 926 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −126 | 203 101 | −0,06 | 74,05 | −9 330 | 15 039 081 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −10 | 52 804 | −0,02 | 74,05 | −740 | 3 909 994 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −141 | 222 061 | −0,06 | 74,05 | −10 441 | 16 443 017 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −24 487 | 10 648 158 | −0,23 | 74,36 | −1 820 848 | 791 794 899 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 759 | 1 669 017 | −0,22 | 74,36 | −279 518 | 124 107 770 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −648 | 321 146 | −0,20 | 74,36 | −48 185 | 23 880 352 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −376 | 203 227 | −0,18 | 74,36 | −27 959 | 15 111 919 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −28 | 52 814 | −0,05 | 74,36 | −2 082 | 3 927 238 | |
2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −419 | 222 202 | −0,19 | 74,36 | −31 157 | 16 522 896 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −55 365 | 10 672 645 | −0,52 | 76,35 | −4 227 024 | 814 838 302 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 499 | 1 672 776 | −0,51 | 76,35 | −648 884 | 127 713 604 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 466 | 321 794 | −0,45 | 76,35 | −111 927 | 24 568 425 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −850 | 203 603 | −0,42 | 76,35 | −64 896 | 15 544 743 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −65 | 52 842 | −0,12 | 76,35 | −4 963 | 4 034 397 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −949 | 222 621 | −0,42 | 76,35 | −72 455 | 16 996 735 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −16 646 | 10 728 010 | −0,15 | 77,66 | −1 292 763 | 833 159 785 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 556 | 1 681 275 | −0,15 | 77,66 | −198 504 | 130 571 347 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −440 | 323 260 | −0,14 | 77,66 | −34 171 | 25 105 050 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −255 | 204 453 | −0,12 | 77,66 | −19 804 | 15 878 249 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −19 | 52 907 | −0,04 | 77,66 | −1 476 | 4 108 869 | |
2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −285 | 223 570 | −0,13 | 77,66 | −22 134 | 17 362 916 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −38 330 | 10 744 656 | −0,36 | 79,13 | −3 033 110 | 850 240 746 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −5 885 | 1 683 831 | −0,35 | 79,13 | −465 689 | 133 244 073 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 014 | 323 700 | −0,31 | 79,13 | −80 239 | 25 614 867 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −588 | 204 708 | −0,29 | 79,13 | −46 529 | 16 198 851 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −45 | 52 926 | −0,08 | 79,13 | −3 561 | 4 188 114 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −657 | 223 855 | −0,29 | 79,13 | −51 989 | 17 713 982 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 296 | 10 782 986 | −0,03 | 80,09 | −263 978 | 863 613 662 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −506 | 1 689 716 | −0,03 | 80,09 | −40 526 | 135 330 030 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −87 | 324 714 | −0,03 | 80,09 | −6 968 | 26 006 474 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −51 | 205 296 | −0,02 | 80,09 | −4 085 | 16 442 239 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 | 52 971 | −0,01 | 80,09 | −320 | 4 242 469 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −56 | 224 512 | −0,02 | 80,09 | −4 485 | 17 981 256 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −53 013 | 10 786 282 | −0,49 | 80,07 | −4 244 714 | 863 650 049 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 139 | 1 690 222 | −0,48 | 80,07 | −651 684 | 135 334 892 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 403 | 324 801 | −0,43 | 80,07 | −112 337 | 26 006 589 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −814 | 205 347 | −0,39 | 80,07 | −65 176 | 16 441 991 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −62 | 52 975 | −0,12 | 80,07 | −4 964 | 4 241 671 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −908 | 224 568 | −0,40 | 80,07 | −72 703 | 17 981 003 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −99 280 | 10 839 295 | −0,91 | 78,09 | −7 752 428 | 846 402 609 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −15 242 | 1 698 361 | −0,89 | 78,09 | −1 190 194 | 132 619 066 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 628 | 326 204 | −0,80 | 78,09 | −205 211 | 25 472 129 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 524 | 206 161 | −0,73 | 78,09 | −119 004 | 16 098 391 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −115 | 53 037 | −0,22 | 78,09 | −8 980 | 4 141 474 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 702 | 225 476 | −0,75 | 78,09 | −132 903 | 17 606 632 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −15 014 | 10 938 575 | −0,14 | 81,26 | −1 220 038 | 888 868 604 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 305 | 1 713 603 | −0,13 | 81,26 | −187 304 | 139 247 380 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −397 | 328 832 | −0,12 | 81,26 | −32 260 | 26 720 888 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −230 | 207 685 | −0,11 | 81,26 | −18 690 | 16 876 483 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −18 | 53 152 | −0,03 | 81,26 | −1 463 | 4 319 132 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −257 | 227 178 | −0,11 | 81,26 | −20 884 | 18 460 484 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −46 511 | 10 953 589 | −0,42 | 81,16 | −3 774 912 | 889 011 904 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −7 140 | 1 715 908 | −0,41 | 81,16 | −579 495 | 139 266 010 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 231 | 329 229 | −0,37 | 81,16 | −99 910 | 26 720 785 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −714 | 207 915 | −0,34 | 81,16 | −57 949 | 16 874 735 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −54 | 53 170 | −0,10 | 81,16 | −4 383 | 4 315 368 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −796 | 227 435 | −0,35 | 81,16 | −64 605 | 18 459 011 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −7 533 | 11 000 100 | −0,07 | 80,51 | −606 473 | 885 604 851 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 156 | 1 723 048 | −0,07 | 80,51 | −93 068 | 138 720 527 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −199 | 330 460 | −0,06 | 80,51 | −16 021 | 26 604 938 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −116 | 208 629 | −0,06 | 80,51 | −9 339 | 16 796 470 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 | 53 224 | −0,02 | 80,51 | −725 | 4 285 000 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −129 | 228 231 | −0,06 | 80,51 | −10 386 | 18 374 604 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 877 | 11 007 633 | −0,11 | 80,38 | −954 711 | 884 828 765 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 824 | 1 724 204 | −0,11 | 80,38 | −146 619 | 138 597 035 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −314 | 330 659 | −0,09 | 80,38 | −25 240 | 26 579 429 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −182 | 208 745 | −0,09 | 80,38 | −14 630 | 16 779 591 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −14 | 53 233 | −0,03 | 80,38 | −1 125 | 4 279 039 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −204 | 228 360 | −0,09 | 80,38 | −16 398 | 18 356 308 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −19 367 | 11 019 510 | −0,18 | 85,11 | −1 648 296 | 937 853 967 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 973 | 1 726 028 | −0,17 | 85,11 | −253 028 | 146 899 654 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −513 | 330 973 | −0,15 | 85,11 | −43 661 | 28 168 616 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −297 | 208 927 | −0,14 | 85,11 | −25 277 | 17 781 464 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −23 | 53 247 | −0,04 | 85,11 | −1 957 | 4 531 772 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −332 | 228 564 | −0,15 | 85,11 | −28 256 | 19 452 739 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −112 010 | 11 038 877 | −1,00 | 82,06 | −9 191 025 | 905 799 468 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −17 198 | 1 729 001 | −0,98 | 82,06 | −1 411 189 | 141 873 869 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 964 | 331 486 | −0,89 | 82,06 | −243 212 | 27 200 216 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 720 | 209 224 | −0,82 | 82,06 | −141 135 | 17 167 959 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −129 | 53 270 | −0,24 | 82,06 | −10 585 | 4 371 091 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 919 | 228 896 | −0,83 | 82,06 | −157 464 | 18 782 153 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −8 157 | 11 150 887 | −0,07 | 82,55 | −673 321 | 920 452 198 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 252 | 1 746 199 | −0,07 | 82,55 | −103 347 | 144 140 346 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −216 | 334 450 | −0,06 | 82,55 | −17 830 | 27 607 242 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −125 | 210 944 | −0,06 | 82,55 | −10 318 | 17 412 415 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 | 53 399 | −0,02 | 82,55 | −743 | 4 407 831 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −140 | 230 815 | −0,06 | 82,55 | −11 556 | 19 052 670 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 120 | 11 159 044 | −0,04 | 83,90 | −345 678 | 936 271 689 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −633 | 1 747 451 | −0,04 | 83,90 | −53 110 | 146 615 508 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −109 | 334 666 | −0,03 | 83,90 | −9 145 | 28 079 314 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −63 | 211 069 | −0,03 | 83,90 | −5 286 | 17 709 217 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −5 | 53 408 | −0,01 | 83,90 | −420 | 4 481 065 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −71 | 230 955 | −0,03 | 83,90 | −5 957 | 19 377 702 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −62 929 | 11 163 164 | −0,56 | 83,20 | −5 235 598 | 928 758 500 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 661 | 1 748 084 | −0,55 | 83,20 | −803 781 | 145 437 967 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 665 | 334 775 | −0,49 | 83,20 | −138 526 | 27 852 778 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −966 | 211 132 | −0,46 | 83,20 | −80 370 | 17 565 866 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −74 | 53 413 | −0,14 | 83,20 | −6 157 | 4 443 881 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 078 | 231 026 | −0,46 | 83,20 | −89 688 | 19 221 017 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −17 602 | 11 226 093 | −0,16 | 85,87 | −1 511 565 | 964 036 246 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 702 | 1 757 745 | −0,15 | 85,87 | −232 033 | 150 945 649 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −466 | 336 440 | −0,14 | 85,87 | −40 018 | 28 891 650 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −270 | 212 098 | −0,13 | 85,87 | −23 186 | 18 213 831 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −21 | 53 487 | −0,04 | 85,87 | −1 803 | 4 593 175 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −302 | 232 104 | −0,13 | 85,87 | −25 934 | 19 931 838 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 120 | 11 243 695 | −0,04 | 82,00 | −337 840 | 921 982 990 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −633 | 1 760 447 | −0,04 | 82,00 | −51 906 | 144 356 654 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −109 | 336 906 | −0,03 | 82,00 | −8 938 | 27 626 292 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −63 | 212 368 | −0,03 | 82,00 | −5 166 | 17 414 176 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −5 | 53 508 | −0,01 | 82,00 | −410 | 4 387 656 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −71 | 232 406 | −0,03 | 82,00 | −5 822 | 19 057 292 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 565 | 11 247 815 | −0,01 | 83,85 | −131 227 | 943 138 286 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −240 | 1 761 080 | −0,01 | 83,85 | −20 124 | 147 667 967 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −42 | 337 015 | −0,01 | 83,85 | −3 522 | 28 258 977 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −24 | 212 431 | −0,01 | 83,85 | −2 012 | 17 812 509 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 | 53 513 | 0,00 | 83,85 | −168 | 4 487 108 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −27 | 232 477 | −0,01 | 83,85 | −2 264 | 19 493 382 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −9 301 | 11 249 380 | −0,08 | 84,84 | −789 121 | 954 426 648 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −1 428 | 1 761 320 | −0,08 | 84,84 | −121 155 | 149 434 968 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −246 | 337 057 | −0,07 | 84,84 | −20 871 | 28 596 792 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −143 | 212 455 | −0,07 | 84,84 | −12 132 | 18 025 235 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 | 53 515 | −0,02 | 84,84 | −933 | 4 540 352 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −159 | 232 504 | −0,07 | 84,84 | −13 490 | 19 726 244 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −21 423 | 11 258 681 | −0,19 | 89,34 | −1 913 901 | 1 005 834 798 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 289 | 1 762 748 | −0,19 | 89,34 | −293 835 | 157 481 438 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −567 | 337 303 | −0,17 | 89,34 | −50 655 | 30 134 178 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −329 | 212 598 | −0,15 | 89,34 | −29 392 | 18 993 208 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −25 | 53 526 | −0,05 | 89,34 | −2 233 | 4 781 938 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −367 | 232 663 | −0,16 | 89,34 | −32 787 | 20 785 787 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −30 555 | 11 280 104 | −0,27 | 85,15 | −2 601 670 | 960 468 143 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 692 | 1 766 037 | −0,26 | 85,15 | −399 510 | 150 372 929 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −809 | 337 870 | −0,24 | 85,15 | −68 884 | 28 768 651 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −470 | 212 927 | −0,22 | 85,15 | −40 019 | 18 130 117 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −37 | 53 551 | −0,07 | 85,15 | −3 150 | 4 559 712 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −522 | 233 030 | −0,22 | 85,15 | −44 447 | 19 841 829 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −36 174 | 11 310 659 | −0,32 | 85,78 | −3 102 970 | 970 217 018 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −5 554 | 1 770 729 | −0,31 | 85,78 | −476 417 | 151 891 363 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −957 | 338 679 | −0,28 | 85,78 | −82 091 | 29 051 546 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −555 | 213 397 | −0,26 | 85,78 | −47 607 | 18 304 981 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −42 | 53 588 | −0,08 | 85,78 | −3 603 | 4 596 725 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −620 | 233 552 | −0,26 | 85,78 | −53 183 | 20 033 857 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 663 | 11 346 833 | −0,03 | 87,30 | −319 780 | 990 579 656 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −562 | 1 776 283 | −0,03 | 87,30 | −49 063 | 155 069 684 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −97 | 339 636 | −0,03 | 87,30 | −8 468 | 29 650 257 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −56 | 213 952 | −0,03 | 87,30 | −4 889 | 18 678 031 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 | 53 630 | −0,01 | 87,30 | −349 | 4 681 904 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −63 | 234 172 | −0,03 | 87,30 | −5 500 | 20 443 239 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −4 306 | 11 350 496 | −0,04 | 88,38 | −380 544 | 1 003 104 624 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −661 | 1 776 845 | −0,04 | 88,38 | −58 416 | 157 029 388 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −114 | 339 733 | −0,03 | 88,38 | −10 075 | 30 024 040 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −66 | 214 008 | −0,03 | 88,38 | −5 833 | 18 913 043 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −5 | 53 634 | −0,01 | 88,38 | −442 | 4 739 926 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −74 | 234 235 | −0,03 | 88,38 | −6 540 | 20 700 612 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −15 798 | 11 354 802 | −0,14 | 83,94 | −1 326 160 | 953 176 583 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −2 425 | 1 777 506 | −0,14 | 83,94 | −203 566 | 149 212 386 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −418 | 339 847 | −0,12 | 83,94 | −35 089 | 28 528 388 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −242 | 214 074 | −0,11 | 83,94 | −20 315 | 17 970 399 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −18 | 53 639 | −0,03 | 83,94 | −1 511 | 4 502 715 | |
2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −271 | 234 309 | −0,12 | 83,94 | −22 749 | 19 669 022 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340 265 | 0,08 | 70,18 | 19 931 | 23 879 798 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340 265 | 0,08 | 70,18 | 19 931 | 23 879 798 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 11 544 497 | 0,00 | 70,18 | 19 931 | 810 192 799 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 1 953 828 | 0,01 | 70,18 | 19 931 | 137 119 649 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 227 554 | 0,12 | 70,18 | 19 931 | 15 969 740 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 388 213 | 0,07 | 70,18 | 19 931 | 27 244 788 | |
2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 340 | 81 414 | 2,96 | 8,71 | 20 381 | 709 116 | |
2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 340 | 81 414 | 2,96 | 8,71 | 20 381 | 709 116 | |
2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 340 | 4 280 212 | 0,05 | 8,71 | 20 381 | 37 280 647 | |
2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810 564 | 0,03 | 69,08 | 18 997 | 55 993 761 | |
2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810 564 | 0,03 | 69,08 | 18 997 | 55 993 761 | |
2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 1 269 837 | 0,02 | 69,08 | 18 997 | 87 720 340 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 131 007 | 24 798 117 | 0,53 | 19,09 | 2 501 238 | 473 455 569 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14 555 | 3 151 020 | 0,46 | 19,09 | 277 890 | 60 160 534 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38 207 | 24 667 110 | 0,16 | 19,01 | 726 353 | 468 946 428 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4 245 | 3 136 465 | 0,14 | 19,01 | 80 702 | 59 627 336 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 920 495 | 24 628 903 | 3,88 | 18,64 | 17 154 897 | 458 999 014 | |
2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102 267 | 3 132 220 | 3,38 | 18,64 | 1 905 909 | 58 373 931 | |
2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16 383 | 632 599 | 2,66 | 1,32 | 21 626 | 835 031 | |
2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16 383 | 632 599 | 2,66 | 1,32 | 21 626 | 835 031 | |
2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16 383 | 34 222 983 | 0,05 | 1,32 | 21 626 | 45 174 338 | |
2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810 289 | 0,03 | 67,00 | 18 961 | 54 289 363 | |
2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810 289 | 0,03 | 67,00 | 18 961 | 54 289 363 | |
2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810 289 | 0,03 | 67,00 | 18 961 | 54 289 363 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339 981 | 0,12 | 50,40 | 19 958 | 17 135 042 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339 981 | 0,12 | 50,40 | 19 958 | 17 135 042 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339 981 | 0,12 | 50,40 | 19 958 | 17 135 042 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 1 953 544 | 0,02 | 50,40 | 19 958 | 98 458 618 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 227 270 | 0,17 | 50,40 | 19 958 | 11 454 408 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 387 929 | 0,10 | 50,40 | 19 958 | 19 551 622 | |
2018-06-21 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100 000 | 100 000 | |||||
2018-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2018-06-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 810 006 | 2,53 | 9,92 | 198 400 | 8 035 260 | |
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 810 006 | 2,53 | 9,92 | 198 400 | 8 035 260 | |
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 810 006 | 2,53 | 9,92 | 198 400 | 8 035 260 | |
2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 349 | 616 216 | 2,21 | 1,62 | 21 625 | 998 270 | |
2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 349 | 616 216 | 2,21 | 1,62 | 21 625 | 998 270 | |
2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 349 | 616 216 | 2,21 | 1,62 | 21 625 | 998 270 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339 585 | 0,19 | 31,29 | 19 963 | 10 625 615 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1 382 967 | 0,05 | 31,29 | 19 963 | 43 273 037 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1 382 967 | 0,05 | 31,29 | 19 963 | 43 273 037 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1 382 967 | 0,05 | 31,29 | 19 963 | 43 273 037 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1 382 967 | 0,05 | 31,29 | 19 963 | 43 273 037 | |
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339 585 | 0,19 | 31,29 | 19 963 | 10 625 615 | |
2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790 006 | 0,03 | 83,33 | 18 999 | 65 831 200 | |
2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 1 249 279 | 0,02 | 83,33 | 18 999 | 104 102 419 | |
2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790 006 | 0,03 | 83,33 | 18 999 | 65 831 200 | |
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | −439 036 | 0 | −100,00 | ||||
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | −17 626 445 | 0 | −100,00 | ||||
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | −2 250 846 | 0 | −100,00 | ||||
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 439 036 | 602 867 | 267,98 | 0,47 | 206 347 | 283 347 | |
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 17 626 445 | 34 193 251 | 106,40 | 0,47 | 8 284 429 | 16 070 828 | |
2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 2 250 846 | 4 102 796 | 121,54 | 0,47 | 1 057 898 | 1 928 314 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 338 947 | 2,49 | 18,50 | 152 625 | 6 270 520 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 338 947 | 2,49 | 18,50 | 152 625 | 6 270 520 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 382 329 | 0,60 | 18,50 | 152 625 | 25 573 086 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 382 329 | 0,60 | 18,50 | 152 625 | 25 573 086 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 382 329 | 0,60 | 18,50 | 152 625 | 25 573 086 | |
2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 338 947 | 2,49 | 18,50 | 152 625 | 6 270 520 | |
2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 333 | 163 831 | 6,04 | 2,21 | 20 626 | 362 067 | |
2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 333 | 163 831 | 6,04 | 2,21 | 20 626 | 362 067 | |
2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 333 | 163 831 | 6,04 | 2,21 | 20 626 | 362 067 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330 697 | 0,18 | 34,20 | 19 973 | 11 309 837 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330 697 | 0,18 | 34,20 | 19 973 | 11 309 837 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1 374 079 | 0,04 | 34,20 | 19 973 | 46 993 502 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1 374 079 | 0,04 | 34,20 | 19 973 | 46 993 502 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1 374 079 | 0,04 | 34,20 | 19 973 | 46 993 502 | |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330 697 | 0,18 | 34,20 | 19 973 | 11 309 837 | |
2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789 778 | 0,03 | 94,71 | 18 942 | 74 799 874 | |
2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789 778 | 0,03 | 94,71 | 18 942 | 74 799 874 | |
2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789 778 | 0,03 | 94,71 | 18 942 | 74 799 874 | |
2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | −39 378 | 0 | −100,00 | ||||
2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | −1 941 | 489 977 | −0,39 | 28,00 | −54 348 | 13 719 356 | |
2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 39 378 | 491 918 | 8,70 | 1,38 | 54 342 | 678 847 | |
2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 204 652 | 16 557 473 | 77,03 | 1,50 | 10 806 978 | 24 836 210 | |
2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 795 348 | 1 842 617 | 75,94 | 1,50 | 1 193 022 | 2 763 926 | |
2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | −1 426 590 | 0 | −100,00 | ||||
2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | −55 457 | 23 708 408 | −0,23 | 35,40 | −1 963 178 | 839 277 643 | |
2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 426 590 | 23 763 865 | 6,39 | 1,38 | 1 968 694 | 32 794 134 | |
2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7 102 | 7 102 | |||||
2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7 102 | 7 102 | |||||
2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | −49 200 | 0 | −100,00 | ||||
2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 045 | 154 498 | 6,22 | 2,28 | 20 623 | 352 255 | |
2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 045 | 154 498 | 6,22 | 2,28 | 20 623 | 352 255 | |
2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 045 | 154 498 | 6,22 | 2,28 | 20 623 | 352 255 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330 113 | 0,19 | 32,09 | 19 960 | 10 593 326 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330 113 | 0,19 | 32,09 | 19 960 | 10 593 326 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1 373 495 | 0,05 | 32,09 | 19 960 | 44 075 455 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1 373 495 | 0,05 | 32,09 | 19 960 | 44 075 455 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1 373 495 | 0,05 | 32,09 | 19 960 | 44 075 455 | |
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330 113 | 0,19 | 32,09 | 19 960 | 10 593 326 | |
2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789 578 | 0,02 | 116,74 | 18 912 | 92 175 336 | |
2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789 578 | 0,02 | 116,74 | 18 912 | 92 175 336 | |
2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789 578 | 0,02 | 116,74 | 18 912 | 92 175 336 | |
2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2 029 | 789 416 | 0,26 | 132,00 | 267 828 | 104 202 912 | |
2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 85 402 | 29 247 347 | 0,29 | 132,00 | 11 273 064 | 3 860 649 804 | |
2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12 569 | 4 386 818 | 0,29 | 132,00 | 1 659 108 | 579 059 976 | |
2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 158 279 | 3 476 256 | 4,77 | 71,00 | 11 237 809 | 246 814 176 | |
2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 17 777 | 372 975 | 5,00 | 71,00 | 1 262 167 | 26 481 225 | |
2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11 787 | 145 453 | 8,82 | 1,75 | 20 627 | 254 543 | |
2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11 787 | 145 453 | 8,82 | 1,75 | 20 627 | 254 543 | |
2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11 787 | 145 453 | 8,82 | 1,75 | 20 627 | 254 543 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1 372 873 | 0,04 | 32,55 | 19 986 | 44 687 016 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1 372 873 | 0,04 | 32,55 | 19 986 | 44 687 016 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1 372 873 | 0,04 | 32,55 | 19 986 | 44 687 016 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1 372 873 | 0,04 | 32,55 | 19 986 | 44 687 016 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1 372 873 | 0,04 | 32,55 | 19 986 | 44 687 016 | |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 329 491 | 0,19 | 32,55 | 19 986 | 10 724 932 | |
2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1 246 660 | 0,01 | 125,91 | 18 886 | 156 966 961 | |
2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1 246 660 | 0,01 | 125,91 | 18 886 | 156 966 961 | |
2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 787 387 | 0,02 | 125,91 | 18 886 | 99 139 897 | |
2017-06-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2017-06-14 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
2017-06-09 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100 000 | 100 000 | |||||
2017-06-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100 000 | 100 000 | |||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 328 877 | 2,57 | 18,13 | 149 572 | 5 962 540 | |
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 372 259 | 0,60 | 18,13 | 149 572 | 24 879 056 | |
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 372 259 | 0,60 | 18,13 | 149 572 | 24 879 056 | |
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 372 259 | 0,60 | 18,13 | 149 572 | 24 879 056 | |
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 372 259 | 0,60 | 18,13 | 149 572 | 24 879 056 | |
2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 328 877 | 2,57 | 18,13 | 149 572 | 5 962 540 | |
2017-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 787 237 | 2,61 | 7,26 | 145 200 | 5 715 341 | |
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 787 237 | 2,61 | 7,26 | 145 200 | 5 715 341 | |
2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 787 237 | 2,61 | 7,26 | 145 200 | 5 715 341 | |
2017-04-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (right to buy) |
A - Award | 399 984 | 399 984 | |||||
2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 487 | 133 666 | 6,78 | 2,43 | 20 623 | 324 808 | |
2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 487 | 133 666 | 6,78 | 2,43 | 20 623 | 324 808 | |
2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 487 | 133 666 | 6,78 | 2,43 | 20 623 | 324 808 | |
2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767 237 | 0,02 | 133,67 | 18 981 | 102 556 570 | |
2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 1 226 510 | 0,01 | 133,67 | 18 981 | 163 947 592 | |
2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767 237 | 0,02 | 133,67 | 18 981 | 102 556 570 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320 627 | 0,20 | 31,49 | 19 965 | 10 096 544 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1 364 009 | 0,05 | 31,49 | 19 965 | 42 952 643 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1 364 009 | 0,05 | 31,49 | 19 965 | 42 952 643 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1 364 009 | 0,05 | 31,49 | 19 965 | 42 952 643 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1 364 009 | 0,05 | 31,49 | 19 965 | 42 952 643 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320 627 | 0,20 | 31,49 | 19 965 | 10 096 544 | |
2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | −6 050 000 | 0 | −100,00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | −5 674 000 | 0 | −100,00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | −243 450 000 | 0 | −100,00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | −228 326 000 | 0 | −100,00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | −25 000 000 | 0 | −100,00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | −25 000 000 | 0 | −100,00 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 121 672 | 767 095 | 18,85 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 111 514 | 645 423 | 20,89 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4 896 067 | 29 141 653 | 20,19 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4 487 412 | 24 245 586 | 22,71 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 502 779 | 4 353 957 | 13,06 | ||||
2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 491 338 | 3 851 178 | 14,62 | ||||
2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14 169 | 125 179 | 12,76 | 1,50 | 21 254 | 187 768 | |
2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14 169 | 125 179 | 12,76 | 1,50 | 21 254 | 187 768 | |
2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14 169 | 125 179 | 12,76 | 1,50 | 21 254 | 187 768 | |
2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993 182 | 0,02 | 100,27 | 18 951 | 99 586 359 | |
2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993 182 | 0,02 | 100,27 | 18 951 | 99 586 359 | |
2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 533 909 | 0,04 | 100,27 | 18 951 | 53 535 055 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14 045 614 | 0,00 | 29,39 | 19 985 | 412 800 595 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14 045 614 | 0,00 | 29,39 | 19 985 | 412 800 595 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14 045 614 | 0,00 | 29,39 | 19 985 | 412 800 595 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14 045 614 | 0,00 | 29,39 | 19 985 | 412 800 595 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 1 363 375 | 0,05 | 29,39 | 19 985 | 40 069 591 | |
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 319 993 | 0,21 | 29,39 | 19 985 | 9 404 594 | |
2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1 594 671 | 3 317 977 | 92,54 | 32,00 | 51 029 472 | 106 175 264 | |
2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 165 824 | 355 198 | 87,56 | 32,00 | 5 306 368 | 11 366 336 | |
2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 928 596 | 9 309 333 | 45,90 | 2,00 | 5 857 192 | 18 618 666 | |
2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 321 404 | 1 003 781 | 47,10 | 2,00 | 642 808 | 2 007 562 | |
2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 299 | 111 010 | 8,08 | 2,56 | 21 245 | 284 186 | |
2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 299 | 111 010 | 8,08 | 2,56 | 21 245 | 284 186 | |
2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 299 | 111 010 | 8,08 | 2,56 | 21 245 | 284 186 | |
2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992 993 | 0,02 | 94,29 | 18 952 | 93 629 310 | |
2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992 993 | 0,02 | 94,29 | 18 952 | 93 629 310 | |
2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 533 720 | 0,04 | 94,29 | 18 952 | 50 324 459 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1 362 695 | 0,05 | 28,92 | 19 955 | 39 409 139 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1 362 695 | 0,05 | 28,92 | 19 955 | 39 409 139 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1 362 695 | 0,05 | 28,92 | 19 955 | 39 409 139 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1 362 695 | 0,05 | 28,92 | 19 955 | 39 409 139 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1 362 695 | 0,05 | 28,92 | 19 955 | 39 409 139 | |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 319 313 | 0,22 | 28,92 | 19 955 | 9 234 532 | |
2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 89 896 | 11 348 958 | 0,80 | 27,02 | 2 428 621 | 306 602 314 | |
2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10 104 | 1 758 289 | 0,58 | 27,02 | 272 969 | 47 501 760 | |
2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 169 877 | 22 337 275 | 5,53 | 33,00 | 38 605 941 | 737 130 075 | |
2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 133 153 | 3 029 953 | 4,60 | 33,00 | 4 394 049 | 99 988 449 | |
2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 038 | 102 711 | 14,54 | 1,63 | 21 252 | 167 419 | |
2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 038 | 102 711 | 14,54 | 1,63 | 21 252 | 167 419 | |
2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 038 | 102 711 | 14,54 | 1,63 | 21 252 | 167 419 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13 937 394 | 0,01 | 26,74 | 19 948 | 372 685 916 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13 937 394 | 0,01 | 26,74 | 19 948 | 372 685 916 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1 362 005 | 0,05 | 26,74 | 19 948 | 36 420 014 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1 362 005 | 0,05 | 26,74 | 19 948 | 36 420 014 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318 623 | 0,23 | 26,74 | 19 948 | 8 519 979 | |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318 623 | 0,23 | 26,74 | 19 948 | 8 519 979 | |
2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 23 803 844 | 0,00 | 79,98 | 18 955 | 1 903 831 443 | |
2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533 519 | 0,04 | 79,98 | 18 955 | 42 670 850 | |
2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533 519 | 0,04 | 79,98 | 18 955 | 42 670 850 | |
2016-06-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70 000 | 70 000 | |||||
2016-06-13 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 26 500 | 26 500 | |||||
2016-06-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2016-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 13 932 918 | 0,06 | 10,73 | 88 522 | 149 500 210 | |
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 13 932 918 | 0,06 | 10,73 | 88 522 | 149 500 210 | |
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 13 932 918 | 0,06 | 10,73 | 88 522 | 149 500 210 | |
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 13 932 918 | 0,06 | 10,73 | 88 522 | 149 500 210 | |
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 13 932 918 | 0,06 | 10,73 | 88 522 | 149 500 210 | |
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | −8 250 | 0 | −100,00 | ||||
2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 317 877 | 2,66 | 10,73 | 88 522 | 3 410 820 | |
2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10 788 | 7 110 113 | 0,15 | 1,97 | 21 252 | 14 006 923 | |
2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10 788 | 89 673 | 13,68 | 1,97 | 21 252 | 176 656 | |
2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10 788 | 89 673 | 13,68 | 1,97 | 21 252 | 176 656 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13 883 418 | 0,01 | 25,48 | 19 976 | 353 749 491 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13 883 418 | 0,01 | 25,48 | 19 976 | 353 749 491 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13 883 418 | 0,01 | 25,48 | 19 976 | 353 749 491 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13 883 418 | 0,01 | 25,48 | 19 976 | 353 749 491 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309 627 | 0,25 | 25,48 | 19 976 | 7 889 296 | |
2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309 627 | 0,25 | 25,48 | 19 976 | 7 889 296 | |
2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533 282 | 0,05 | 72,47 | 18 987 | 38 646 947 | |
2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533 282 | 0,05 | 72,47 | 18 987 | 38 646 947 | |
2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533 282 | 0,05 | 72,47 | 18 987 | 38 646 947 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 262 253 | 21 167 398 | 1,25 | 28,55 | 7 486 904 | 604 295 345 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28 647 | 2 896 800 | 1,00 | 28,55 | 817 826 | 82 699 005 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10 818 | 20 905 145 | 0,05 | 27,82 | 300 959 | 581 585 315 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 182 | 2 868 153 | 0,04 | 27,82 | 32 883 | 79 792 590 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 318 969 | 20 894 327 | 1,55 | 27,72 | 8 840 959 | 579 134 330 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 34 844 | 2 866 971 | 1,23 | 27,72 | 965 782 | 79 464 695 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 60 587 | 20 575 358 | 0,30 | 27,56 | 1 669 705 | 567 032 176 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6 618 | 2 832 127 | 0,23 | 27,56 | 182 384 | 78 050 022 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28 433 | 20 514 771 | 0,14 | 26,55 | 755 024 | 544 759 487 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 106 | 2 825 509 | 0,11 | 26,55 | 82 478 | 75 029 979 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 180 122 | 20 486 338 | 0,89 | 26,49 | 4 772 224 | 542 773 234 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19 676 | 2 822 403 | 0,70 | 26,49 | 521 304 | 74 777 874 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13 433 | 20 306 216 | 0,07 | 26,28 | 353 086 | 533 748 888 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 467 | 2 802 727 | 0,05 | 26,28 | 38 560 | 73 669 679 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14 775 | 20 292 783 | 0,07 | 25,61 | 378 343 | 519 637 294 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 614 | 2 801 260 | 0,06 | 25,61 | 41 330 | 71 731 865 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 16 057 | 2 799 646 | 0,58 | 26,35 | 423 057 | 73 762 833 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 37 882 | 2 783 589 | 1,38 | 25,98 | 983 985 | 72 303 724 | |
2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 408 607 | 2 745 707 | 17,48 | 25,92 | 10 593 014 | 71 181 630 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 206 421 153 | 0,01 | 3,86 | 77 200 | 796 785 651 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 90 179 | 19 757 285 | 0,46 | 62,59 | 5 644 024 | 1 236 547 221 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9 821 | 3 358 951 | 0,29 | 62,59 | 614 666 | 210 226 330 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 127 964 | 19 667 106 | 0,65 | 61,38 | 7 854 149 | 1 207 123 699 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13 936 | 3 349 130 | 0,42 | 61,38 | 855 361 | 205 562 231 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 24 431 | 19 539 142 | 0,13 | 61,03 | 1 490 975 | 1 192 434 758 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2 660 | 3 335 194 | 0,08 | 61,03 | 162 334 | 203 540 219 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20 659 | 19 514 711 | 0,11 | 60,95 | 1 259 178 | 1 189 433 344 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2 250 | 3 332 534 | 0,07 | 60,95 | 137 139 | 203 119 947 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 97 484 | 19 494 052 | 0,50 | 60,85 | 5 931 960 | 1 186 224 761 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10 616 | 3 330 284 | 0,32 | 60,85 | 645 990 | 202 649 780 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 533 020 | 3,90 | 3,86 | 77 200 | 2 057 457 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 533 020 | 3,90 | 3,86 | 77 200 | 2 057 457 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 182 | 19 376 568 | 0,01 | 65,29 | 77 176 | 1 265 142 628 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 129 | 3 299 668 | 0,00 | 65,29 | 8 423 | 215 443 243 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 179 176 | 19 375 386 | 0,93 | 65,80 | 11 789 387 | 1 274 857 773 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19 513 | 3 299 539 | 0,59 | 65,80 | 1 283 912 | 217 102 407 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 180 358 | 19 196 210 | 0,95 | 67,15 | 12 110 607 | 1 288 979 431 | |
2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19 642 | 3 280 026 | 0,60 | 67,15 | 1 318 913 | 220 245 874 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6 022 | 19 015 852 | 0,03 | 74,00 | 445 628 | 1 407 173 048 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 678 | 3 260 384 | 0,02 | 74,00 | 50 172 | 241 268 416 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20 492 | 19 009 830 | 0,11 | 69,70 | 1 428 282 | 1 324 975 646 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2 308 | 3 259 706 | 0,07 | 69,70 | 160 866 | 227 199 878 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 23 157 | 18 989 338 | 0,12 | 70,50 | 1 632 684 | 1 338 843 276 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2 608 | 3 257 398 | 0,08 | 70,50 | 183 877 | 229 662 846 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8 111 | 18 966 181 | 0,04 | 71,96 | 583 702 | 1 364 886 043 | |
2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 914 | 3 254 790 | 0,03 | 71,96 | 65 775 | 234 228 359 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15 187 | 18 958 070 | 0,08 | 69,45 | 1 054 742 | 1 316 643 649 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 651 | 3 253 876 | 0,05 | 69,45 | 114 662 | 225 982 664 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8 250 | 18 942 883 | 0,04 | 70,86 | 584 597 | 1 342 296 478 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 897 | 3 252 225 | 0,03 | 70,86 | 63 562 | 230 453 314 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 67 373 | 18 934 633 | 0,36 | 69,54 | 4 684 923 | 1 316 659 468 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7 326 | 3 251 328 | 0,23 | 69,54 | 509 429 | 226 087 920 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 124 057 | 18 867 260 | 0,66 | 70,21 | 8 710 228 | 1 324 698 625 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13 490 | 3 244 002 | 0,42 | 70,21 | 947 153 | 227 766 246 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 397 079 | 18 743 203 | 2,16 | 71,10 | 28 233 945 | 1 332 718 580 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 43 178 | 3 230 512 | 1,35 | 71,10 | 3 070 133 | 229 702 648 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 149 927 | 18 346 124 | 0,82 | 67,94 | 10 186 595 | 1 246 503 545 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 16 450 | 3 187 334 | 0,52 | 67,94 | 1 117 674 | 216 559 265 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 38 117 | 18 196 197 | 0,21 | 63,98 | 2 438 547 | 1 164 107 162 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 4 183 | 3 170 884 | 0,13 | 63,98 | 267 609 | 202 858 255 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 168 055 | 18 158 080 | 0,93 | 64,87 | 10 902 350 | 1 177 981 834 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 18 441 | 3 166 701 | 0,59 | 64,87 | 1 196 336 | 205 435 611 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 541 340 | 17 990 025 | 3,10 | 65,80 | 35 621 958 | 1 183 803 012 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 59 401 | 3 148 260 | 1,92 | 65,80 | 3 908 782 | 207 165 897 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 49 021 | 17 448 685 | 0,28 | 66,68 | 3 268 823 | 1 163 514 958 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5 379 | 3 088 859 | 0,17 | 66,68 | 358 683 | 205 971 605 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72 894 | 17 399 664 | 0,42 | 67,68 | 4 933 706 | 1 177 666 678 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7 999 | 3 083 480 | 0,26 | 67,68 | 541 399 | 208 700 102 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6 939 | 17 326 770 | 0,04 | 60,85 | 422 220 | 1 054 288 905 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 761 | 3 075 481 | 0,02 | 60,85 | 46 305 | 187 135 023 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 57 865 | 17 319 831 | 0,34 | 61,73 | 3 572 047 | 1 069 165 292 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6 349 | 3 074 720 | 0,21 | 61,73 | 391 928 | 189 804 618 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 136 793 | 17 261 966 | 0,80 | 58,13 | 7 952 133 | 1 003 482 965 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15 010 | 3 068 371 | 0,49 | 58,13 | 872 570 | 178 372 384 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 114 908 | 17 125 173 | 0,68 | 59,01 | 6 780 526 | 1 010 527 346 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12 609 | 3 053 361 | 0,41 | 59,01 | 744 036 | 180 173 642 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65 309 | 17 010 265 | 0,39 | 60,40 | 3 944 513 | 1 027 380 882 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7 166 | 3 040 752 | 0,24 | 60,40 | 432 810 | 183 654 427 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 113 546 | 16 944 956 | 0,67 | 61,40 | 6 971 475 | 1 040 383 019 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12 459 | 3 033 586 | 0,41 | 61,40 | 764 955 | 186 255 507 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 289 755 | 16 831 410 | 1,75 | 62,56 | 18 126 986 | 1 052 967 960 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 31 795 | 3 021 127 | 1,06 | 62,56 | 1 989 086 | 189 000 799 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 176 647 | 16 541 655 | 1,08 | 63,37 | 11 194 368 | 1 048 267 836 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19 383 | 2 989 332 | 0,65 | 63,37 | 1 228 328 | 189 438 154 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 235 734 | 16 365 008 | 1,46 | 64,46 | 15 195 814 | 1 054 916 236 | |
2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25 869 | 2 969 949 | 0,88 | 64,46 | 1 667 560 | 191 447 961 | |
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | −56 853 | 0 | −100,00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | −2 296 890 | 0 | −100,00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | −238 850 | 0 | −100,00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | −26 292 961 | 0 | −100,00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | −1 912 167 | 0 | −100,00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | −582 747 | 0 | −100,00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | −44 572 171 | 0 | −100,00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | −4 382 118 | 0 | −100,00 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1 723 306 | 1 723 306 | 24,00 | 41 359 344 | 41 359 344 | ||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 189 374 | 189 374 | 24,00 | 4 544 976 | 4 544 976 | ||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 56 853 | 639 600 | 9,76 | 0,68 | 38 376 | 431 730 | |
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 2 296 890 | 73 162 022 | 3,24 | 0,68 | 1 550 401 | 49 384 365 | |
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 238 850 | 6 533 135 | 3,79 | 0,68 | 161 224 | 4 409 866 | |
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 26 292 961 | 70 865 132 | 58,99 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 1 912 167 | 6 294 285 | 43,64 | ||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 582 747 | 582 747 | |||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 44 572 171 | 44 572 171 | |||||
2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 4 382 118 | 4 382 118 | |||||
2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 801 161 | 20 278 008 | 9,75 | 29,00 | 52 233 669 | 588 062 232 | |
2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785 045 | 2 337 100 | 50,58 | 29,00 | 22 766 305 | 67 775 900 | |
2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 801 161 | 20 278 008 | 9,75 | 29,00 | 52 233 669 | 588 062 232 | |
2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785 045 | 2 337 100 | 50,58 | 29,00 | 22 766 305 | 67 775 900 | |
2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7 082 | 78 885 | 9,86 | 3,00 | 21 246 | 236 655 | |
2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7 082 | 78 885 | 9,86 | 3,00 | 21 246 | 236 655 | |
2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7 082 | 6 348 612 | 0,11 | 3,00 | 21 246 | 19 045 836 | |
2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513 020 | 0,03 | 108,45 | 18 979 | 55 637 019 | |
2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513 020 | 0,03 | 108,45 | 18 979 | 55 637 019 | |
2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 666 111 | 0,03 | 108,45 | 18 979 | 72 239 738 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308 843 | 0,18 | 35,20 | 19 994 | 10 871 274 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308 843 | 0,18 | 35,20 | 19 994 | 10 871 274 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 482 740 | 0,12 | 35,20 | 19 994 | 16 992 448 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 11 423 179 | 0,00 | 35,20 | 19 994 | 402 095 901 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 196 132 | 0,29 | 35,20 | 19 994 | 6 903 846 | |
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 356 791 | 0,16 | 35,20 | 19 994 | 12 559 043 | |
2015-12-15 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 945 | 71 803 | 10,71 | 3,06 | 21 252 | 219 717 | |
2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 945 | 71 803 | 10,71 | 3,06 | 21 252 | 219 717 | |
2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 945 | 71 803 | 10,71 | 3,06 | 21 252 | 219 717 | |
2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 512 845 | 0,03 | 110,33 | 18 977 | 56 582 189 | |
2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 972 118 | 0,02 | 110,33 | 18 977 | 107 253 779 | |
2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 16 282 190 | 0,00 | 110,33 | 18 977 | 1 796 414 023 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308 275 | 0,30 | 21,34 | 19 974 | 6 578 588 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308 275 | 0,30 | 21,34 | 19 974 | 6 578 588 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 11 422 611 | 0,01 | 21,34 | 19 974 | 243 758 519 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 1 911 734 | 0,05 | 21,34 | 19 974 | 40 796 404 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 195 564 | 0,48 | 21,34 | 19 974 | 4 173 336 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 356 223 | 0,26 | 21,34 | 19 974 | 7 601 799 | |
2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | −892 000 | 0 | −100,00 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | −31 967 000 | 0 | −100,00 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | −7 587 000 | 0 | −100,00 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | −65 000 | 0 | −100,00 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | −64 000 | 0 | −100,00 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 101 652 | 512 673 | 24,73 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 3 642 962 | 16 128 927 | 29,18 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 864 614 | 2 943 733 | 41,59 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7 406 | 61 049 | 13,81 | ||||
2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7 292 | 58 632 | 14,20 | ||||
2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −229 436 | 90 538 | −71,70 | 1,09 | −250 659 | 98 913 | |
2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −9 411 311 | 3 153 539 | −74,90 | 1,09 | −10 281 857 | 3 445 241 | |
2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −1 359 253 | 467 436 | −74,41 | 1,09 | −1 484 984 | 510 674 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 307 339 | 0,24 | 27,34 | 19 958 | 8 402 648 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 1 350 721 | 0,05 | 27,34 | 19 958 | 36 928 712 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 481 236 | 0,15 | 27,34 | 19 958 | 13 156 992 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 11 421 675 | 0,01 | 27,34 | 19 958 | 312 268 594 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 194 628 | 0,38 | 27,34 | 19 958 | 5 321 130 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 355 287 | 0,21 | 27,34 | 19 958 | 9 713 547 | |
2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 826 200 | 0,02 | 104,21 | 18 966 | 86 098 302 | |
2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 411 021 | 0,04 | 104,21 | 18 966 | 42 832 498 | |
2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 549 414 | 0,03 | 104,21 | 18 966 | 57 254 433 | |
2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 260 | 64 858 | 8,83 | 3,66 | 19 252 | 237 380 | |
2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 260 | 64 858 | 8,83 | 3,66 | 19 252 | 237 380 | |
2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 260 | 64 858 | 8,83 | 3,66 | 19 252 | 237 380 | |
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 250 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 250 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 250 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 500 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 500 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 500 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −3 000 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −3 000 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −15 000 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −7 500 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −7 500 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −7 500 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 250 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 750 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 750 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 750 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | −9 184 771 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | −12 250 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | −12 250 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | −12 250 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | −12 250 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | −12 250 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | −680 187 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | −143 462 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | −200 526 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −7 500 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −7 500 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −7 500 | 0 | −100,00 | ||||
2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −15 000 | 0 | −100,00 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 21 196 | 100 523 | 26,72 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | −211 614 | 12 250 | −94,53 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 497 | 79 327 | 0,63 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | −100 490 | 12 250 | −89,13 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 40 449 | 78 830 | 105,39 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | −1 068 128 | 680 187 | −61,09 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 5 543 | 38 381 | 16,88 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | −55 479 | 12 250 | −81,91 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 12 500 | 32 838 | 61,46 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | −165 213 | 12 250 | −93,10 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 19 318 | 20 338 | 1 893,92 | ||||
2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | −206 800 | 12 250 | −94,41 | ||||
2015-06-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 500 | 12 500 | |||||
2015-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2015-06-10 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70 000 | 70 000 | |||||
2015-05-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 410 839 | 5,12 | 7,68 | 153 600 | 3 155 244 | |
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 410 839 | 5,12 | 7,68 | 153 600 | 3 155 244 | |
2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 410 839 | 5,12 | 7,68 | 153 600 | 3 155 244 | |
2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 470 | 59 598 | 10,11 | 3,52 | 19 254 | 209 785 | |
2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 470 | 59 598 | 10,11 | 3,52 | 19 254 | 209 785 | |
2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 470 | 59 598 | 10,11 | 3,52 | 19 254 | 209 785 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306 609 | 0,21 | 30,43 | 19 962 | 9 330 112 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1 349 991 | 0,05 | 30,43 | 19 962 | 41 080 226 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1 349 991 | 0,05 | 30,43 | 19 962 | 41 080 226 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1 349 991 | 0,05 | 30,43 | 19 962 | 41 080 226 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1 349 991 | 0,05 | 30,43 | 19 962 | 41 080 226 | |
2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306 609 | 0,21 | 30,43 | 19 962 | 9 330 112 | |
2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 898 409 | 6 323 855 | 343,64 | 3,75 | 18 369 034 | 23 714 456 | |
2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 434 924 | 625 495 | 228,22 | 3,75 | 1 630 965 | 2 345 606 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −21 441 | 345 074 | −5,85 | 3,86 | −82 762 | 1 331 986 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −859 988 | 12 589 950 | −6,39 | 3,86 | −3 319 554 | 48 597 207 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −118 571 | 1 851 789 | −6,02 | 3,86 | −457 684 | 7 147 906 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −21 548 | 366 515 | −5,55 | 3,81 | −82 130 | 1 396 972 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −863 100 | 13 449 938 | −6,03 | 3,81 | −3 289 706 | 51 264 439 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −118 652 | 1 970 360 | −5,68 | 3,81 | −452 242 | 7 510 027 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −4 554 | 388 063 | −1,16 | 3,55 | −16 184 | 1 379 059 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −182 454 | 14 313 038 | −1,26 | 3,55 | −648 387 | 50 864 243 | |
2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −25 092 | 2 089 012 | −1,19 | 3,55 | −89 169 | 7 423 722 | |
2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 927 | 54 128 | 7,82 | 4,90 | 19 242 | 265 227 | |
2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 927 | 54 128 | 7,82 | 4,90 | 19 242 | 265 227 | |
2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 927 | 1 425 446 | 0,28 | 4,90 | 19 242 | 6 984 685 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 305 953 | 0,20 | 31,97 | 19 949 | 9 781 317 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1 349 335 | 0,05 | 31,97 | 19 949 | 43 138 240 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 11 420 289 | 0,01 | 31,97 | 19 949 | 365 106 639 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1 909 412 | 0,03 | 31,97 | 19 949 | 61 043 902 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 193 242 | 0,32 | 31,97 | 19 949 | 6 177 947 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 353 901 | 0,18 | 31,97 | 19 949 | 11 314 215 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −8 415 | 392 617 | −2,10 | 3,65 | −30 711 | 1 432 856 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −337 123 | 14 495 492 | −2,27 | 3,65 | −1 230 330 | 52 901 298 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −46 362 | 2 114 104 | −2,15 | 3,65 | −169 198 | 7 715 423 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −4 746 | 401 032 | −1,17 | 3,68 | −17 447 | 1 474 274 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −190 117 | 14 832 615 | −1,27 | 3,68 | −698 908 | 54 527 659 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −26 137 | 2 160 466 | −1,20 | 3,68 | −96 085 | 7 942 305 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −2 825 | 405 778 | −0,69 | 3,71 | −10 482 | 1 505 680 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −112 855 | 15 022 732 | −0,75 | 3,71 | −418 760 | 55 743 349 | |
2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −15 420 | 2 186 603 | −0,70 | 3,71 | −57 217 | 8 113 609 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −16 182 | 408 603 | −3,81 | 4,21 | −68 102 | 1 719 606 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −647 781 | 15 135 587 | −4,10 | 4,21 | −2 726 186 | 63 698 118 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −88 937 | 2 202 023 | −3,88 | 4,21 | −374 291 | 9 267 214 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −3 558 | 424 785 | −0,83 | 4,29 | −15 260 | 1 821 903 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −142 543 | 15 783 368 | −0,90 | 4,29 | −611 367 | 67 694 865 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −19 599 | 2 290 960 | −0,85 | 4,29 | −84 060 | 9 825 927 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −14 753 | 428 343 | −3,33 | 4,31 | −63 571 | 1 845 730 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −590 638 | 15 925 911 | −3,58 | 4,31 | −2 545 059 | 68 624 750 | |
2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −81 109 | 2 310 559 | −3,39 | 4,31 | −349 499 | 9 956 199 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −6 874 | 443 096 | −1,53 | 4,27 | −29 358 | 1 892 419 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −274 734 | 16 516 549 | −1,64 | 4,27 | −1 173 361 | 70 540 529 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −37 592 | 2 391 668 | −1,55 | 4,27 | −160 552 | 10 214 575 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −9 908 | 449 970 | −2,15 | 4,45 | −44 093 | 2 002 456 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −396 496 | 16 791 283 | −2,31 | 4,45 | −1 764 486 | 74 724 568 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −54 396 | 2 429 260 | −2,19 | 4,45 | −242 073 | 10 810 693 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −5 457 | 459 878 | −1,17 | 4,71 | −25 724 | 2 167 865 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −218 383 | 17 187 779 | −1,25 | 4,71 | −1 029 457 | 81 023 190 | |
2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −29 960 | 2 483 656 | −1,19 | 4,71 | −141 231 | 11 707 954 | |
2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −8 429 | 465 335 | −1,78 | 4,62 | −38 907 | 2 147 940 | |
2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −337 541 | 17 406 162 | −1,90 | 4,62 | −1 558 056 | 80 345 103 | |
2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −46 383 | 2 513 616 | −1,81 | 4,62 | −214 099 | 11 602 600 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100 000 | 21 109 766 | 0,48 | 34,95 | 3 495 000 | 737 786 322 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 354 000 | 21 009 766 | 1,71 | 34,27 | 12 131 651 | 720 008 883 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14 772 | 20 655 766 | 0,07 | 34,53 | 510 114 | 713 295 239 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185 378 | 20 640 994 | 0,91 | 34,33 | 6 364 935 | 708 706 465 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30 507 | 107 504 | 39,62 | ||||
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30 507 | 3 993 087 | 0,77 | ||||
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | −399 208 | 0 | −100,00 | ||||
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 500 | 20 455 616 | 0,03 | 33,90 | 186 438 | 693 400 380 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 80 430 | 20 450 116 | 0,39 | 34,64 | 2 786 393 | 708 467 684 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42 500 | 20 369 686 | 0,21 | 33,28 | 1 414 515 | 677 958 148 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185 528 | 20 327 186 | 0,92 | 33,31 | 6 180 420 | 677 151 416 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 216 284 | 20 141 658 | 1,09 | 32,56 | 7 043 267 | 655 911 079 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38 614 | 19 925 374 | 0,19 | 33,00 | 1 274 254 | 657 533 357 | |
2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24 890 | 19 886 760 | 0,13 | 33,06 | 822 744 | 657 360 829 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −28 086 | 473 764 | −5,60 | 4,55 | −127 671 | 2 153 589 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −1 122 584 | 17 743 703 | −5,95 | 4,55 | −5 102 930 | 80 657 551 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −153 618 | 2 559 999 | −5,66 | 4,55 | −698 301 | 11 636 987 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −11 965 | 501 850 | −2,33 | 4,84 | −57 913 | 2 429 054 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −486 800 | 18 866 287 | −2,52 | 4,84 | −2 356 209 | 91 316 602 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −69 153 | 2 713 617 | −2,49 | 4,84 | −334 714 | 13 134 449 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −10 534 | 513 815 | −2,01 | 5,36 | −56 453 | 2 753 586 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −428 583 | 19 353 087 | −2,17 | 5,36 | −2 296 819 | 103 715 129 | |
2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | −60 883 | 2 782 770 | −2,14 | 5,36 | −326 278 | 14 913 143 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98 076 | 19 861 870 | 0,50 | 36,57 | 3 586 737 | 726 368 448 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 639 | 19 763 794 | 0,05 | 36,75 | 390 999 | 726 349 075 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69 397 | 19 753 155 | 0,35 | 35,88 | 2 490 291 | 708 836 041 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63 137 | 19 683 758 | 0,32 | 36,74 | 2 319 502 | 723 134 028 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25 505 | 19 620 621 | 0,13 | 35,91 | 915 851 | 704 550 993 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22 839 | 19 595 116 | 0,12 | 35,55 | 811 963 | 696 637 726 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 116 | 19 572 277 | 0,07 | 35,56 | 466 413 | 696 001 913 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 17 098 | 19 559 161 | 0,09 | 34,91 | 596 816 | 682 724 250 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 104 140 | 19 542 063 | 0,54 | 35,98 | 3 746 947 | 703 121 473 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29 006 | 19 437 923 | 0,15 | 35,28 | 1 023 471 | 685 863 225 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 500 | 19 408 917 | 0,07 | 34,26 | 462 530 | 664 978 610 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25 769 | 19 395 417 | 0,13 | 34,58 | 890 989 | 670 615 938 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 866 669 | 19 369 648 | 4,68 | 33,79 | 29 287 172 | 654 554 641 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 394 | 18 502 979 | 0,02 | 33,71 | 148 139 | 623 807 584 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38 166 | 18 498 585 | 0,21 | 34,83 | 1 329 390 | 644 339 013 | |
2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 252 474 | 18 460 419 | 1,39 | 34,41 | 8 686 949 | 635 173 175 | |
2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 914 | 50 201 | 21,59 | 2,16 | 19 254 | 108 434 | |
2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 914 | 50 201 | 21,59 | 2,16 | 19 254 | 108 434 | |
2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 914 | 1 421 519 | 0,63 | 2,16 | 19 254 | 3 070 481 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305 329 | 0,23 | 28,54 | 19 978 | 8 714 090 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305 329 | 0,23 | 28,54 | 19 978 | 8 714 090 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 1 348 711 | 0,05 | 28,54 | 19 978 | 38 492 212 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 11 419 665 | 0,01 | 28,54 | 19 978 | 325 917 239 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 192 618 | 0,36 | 28,54 | 19 978 | 5 497 318 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 353 277 | 0,20 | 28,54 | 19 978 | 10 082 526 | |
2014-09-16 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 7 000 | 7 000 | |||||
2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5 500 | 524 349 | 1,06 | ||||
2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5 500 | 524 349 | 1,06 | ||||
2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5 500 | 524 349 | 1,06 | ||||
2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 182 | 41 287 | 17,61 | 2,83 | 17 495 | 116 842 | |
2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 182 | 41 287 | 17,61 | 2,83 | 17 495 | 116 842 | |
2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 182 | 1 412 605 | 0,44 | 2,83 | 17 495 | 3 997 672 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 304 629 | 0,24 | 27,86 | 19 948 | 8 486 964 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1 348 011 | 0,05 | 27,86 | 19 948 | 37 555 586 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 11 418 965 | 0,01 | 27,86 | 19 948 | 318 132 365 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1 908 088 | 0,04 | 27,86 | 19 948 | 53 159 332 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 191 918 | 0,37 | 27,86 | 19 948 | 5 346 835 | |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 352 577 | 0,20 | 27,86 | 19 948 | 9 822 795 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −4 250 | 0 | −100,00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −4 250 | 0 | −100,00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −4 250 | 0 | −100,00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −4 250 | 0 | −100,00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −4 250 | 0 | −100,00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −4 250 | 0 | −100,00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −4 250 | 0 | −100,00 | ||||
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4 250 | 223 864 | 1,94 | 60,45 | 256 912 | 13 532 579 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4 250 | 223 864 | 1,94 | 60,45 | 256 912 | 13 532 579 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4 250 | 223 864 | 1,94 | 60,45 | 256 912 | 13 532 579 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4 250 | 257 722 | 1,68 | 60,45 | 256 912 | 15 579 295 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4 250 | 1 893 297 | 0,22 | 60,45 | 256 912 | 114 449 804 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4 250 | 212 711 | 2,04 | 60,45 | 256 912 | 12 858 380 | |
2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4 250 | 322 445 | 1,34 | 60,45 | 256 912 | 19 491 800 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 670 | 416 208 | 0,16 | 39,80 | 26 668 | 16 566 494 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 27 046 | 18 207 945 | 0,15 | 39,80 | 1 076 523 | 724 738 118 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 471 | 415 538 | 0,36 | 39,93 | 58 731 | 16 590 770 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59 400 | 18 180 899 | 0,33 | 39,93 | 2 371 604 | 725 890 573 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 938 | 414 067 | 0,47 | 39,99 | 77 503 | 16 559 036 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78 262 | 18 121 499 | 0,43 | 39,99 | 3 129 791 | 724 700 491 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 155 | 412 129 | 0,28 | 39,84 | 46 021 | 16 421 239 | |
2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46 653 | 18 043 237 | 0,26 | 39,84 | 1 858 884 | 718 930 974 | |
2014-06-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70 000 | 70 000 | |||||
2014-06-10 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 500 | 12 500 | |||||
2014-06-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 534 | 410 974 | 1,36 | 38,96 | 215 578 | 16 009 574 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 223 466 | 17 996 584 | 1,26 | 38,96 | 8 705 163 | 701 060 529 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 534 | 405 440 | 0,13 | 38,56 | 20 591 | 15 633 847 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21 559 | 17 773 118 | 0,12 | 38,56 | 831 319 | 685 334 985 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 477 | 404 906 | 0,12 | 37,52 | 17 895 | 15 190 413 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 223 | 17 751 559 | 0,11 | 37,52 | 721 168 | 665 965 712 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 757 | 404 429 | 0,94 | 37,40 | 140 504 | 15 124 795 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151 530 | 17 732 336 | 0,86 | 37,40 | 5 666 904 | 663 152 128 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 411 | 400 672 | 0,61 | 37,67 | 90 826 | 15 093 995 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97 254 | 17 580 806 | 0,56 | 37,67 | 3 663 724 | 662 298 849 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 496 | 398 261 | 0,12 | 37,63 | 18 667 | 14 988 274 | |
2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20 011 | 17 483 552 | 0,11 | 37,63 | 753 100 | 657 981 241 | |
2014-06-06 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 534 | 397 765 | 0,39 | 36,04 | 55 281 | 14 334 377 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61 878 | 17 463 541 | 0,36 | 36,04 | 2 229 916 | 629 338 866 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 572 | 396 231 | 0,14 | 36,39 | 20 817 | 14 419 995 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23 058 | 17 401 663 | 0,13 | 36,39 | 839 147 | 633 296 981 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 | 395 659 | 0,00 | 35,27 | 670 | 13 956 001 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 781 | 17 378 605 | 0,00 | 35,27 | 27 548 | 612 992 058 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 137 | 395 640 | 0,54 | 34,38 | 73 479 | 13 603 725 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 86 201 | 17 377 824 | 0,50 | 34,38 | 2 963 944 | 597 520 838 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 270 | 393 503 | 0,07 | 35,11 | 9 481 | 13 817 386 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 896 | 17 291 623 | 0,06 | 35,11 | 382 600 | 607 174 592 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 809 | 393 233 | 0,46 | 34,05 | 61 604 | 13 391 196 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72 980 | 17 280 727 | 0,42 | 34,05 | 2 485 268 | 588 479 605 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 480 | 391 424 | 0,12 | 34,21 | 16 421 | 13 391 046 | |
2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 348 | 17 207 747 | 0,11 | 34,21 | 661 916 | 588 695 953 | |
2014-05-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2014-05-27 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11 600 | 11 600 | |||||
2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8 400 | 518 849 | 1,65 | ||||
2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8 400 | 518 849 | 1,65 | ||||
2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8 400 | 518 849 | 1,65 | ||||
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10 000 | 390 839 | 2,63 | 7,02 | 70 200 | 2 743 690 | |
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10 000 | 390 839 | 2,63 | 7,02 | 70 200 | 2 743 690 | |
2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10 000 | 390 839 | 2,63 | 7,02 | 70 200 | 2 743 690 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8 750 | 8 750 | |||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8 750 | 8 750 | |||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8 750 | 8 750 | |||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 151 | 390 944 | 0,30 | 34,08 | 39 232 | 13 325 287 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46 460 | 17 188 399 | 0,27 | 34,08 | 1 583 584 | 585 864 861 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 921 | 389 793 | 0,76 | 34,03 | 99 415 | 13 266 449 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 117 879 | 17 141 939 | 0,69 | 34,03 | 4 011 965 | 583 419 037 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 500 | 386 872 | 0,91 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 500 | 386 872 | 0,91 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 500 | 17 178 061 | 0,02 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 505 | 383 372 | 0,13 | 34,26 | 17 304 | 13 136 012 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20 395 | 17 020 560 | 0,12 | 34,26 | 698 822 | 583 199 276 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 | 382 867 | 0,00 | 34,10 | 239 | 13 055 765 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 293 | 17 000 165 | 0,00 | 34,10 | 9 991 | 579 705 626 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 382 860 | 2,68 | 7,26 | 72 600 | 2 779 564 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 382 860 | 2,68 | 7,26 | 72 600 | 2 779 564 | |
2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 382 860 | 2,68 | 7,26 | 72 600 | 2 779 564 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372 860 | 0,20 | 34,60 | 25 815 | 12 902 522 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30 122 | 16 989 872 | 0,18 | 34,60 | 1 042 348 | 587 920 929 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372 114 | 0,20 | 33,73 | 24 964 | 12 553 191 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29 865 | 16 959 750 | 0,18 | 33,73 | 1 007 490 | 572 133 774 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 069 | 371 374 | 0,29 | 34,31 | 36 673 | 12 740 319 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43 131 | 16 929 885 | 0,26 | 34,31 | 1 479 648 | 580 794 942 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370 305 | 0,21 | 33,92 | 26 559 | 12 560 486 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31 617 | 16 886 754 | 0,19 | 33,92 | 1 072 427 | 572 786 875 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369 522 | 0,09 | 34,74 | 11 430 | 12 837 564 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 271 | 16 855 137 | 0,08 | 34,74 | 461 048 | 585 564 315 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 933 | 369 193 | 0,80 | 33,77 | 99 060 | 12 469 235 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118 389 | 16 841 866 | 0,71 | 33,77 | 3 998 506 | 568 822 235 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366 260 | 0,23 | 33,72 | 28 295 | 12 352 009 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33 868 | 16 723 477 | 0,20 | 34,72 | 1 176 056 | 580 717 722 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 534 | 365 421 | 0,42 | 33,98 | 52 118 | 12 415 252 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61 892 | 16 689 609 | 0,37 | 33,98 | 2 102 793 | 567 032 804 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363 887 | 0,17 | 34,01 | 21 190 | 12 376 779 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25 156 | 16 627 717 | 0,15 | 34,01 | 855 623 | 565 553 550 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 228 | 363 264 | 0,34 | 33,40 | 41 020 | 12 134 580 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49 553 | 16 602 561 | 0,30 | 33,40 | 1 655 283 | 554 596 928 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362 036 | 0,27 | 33,54 | 33 007 | 12 143 991 | |
2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 710 | 16 553 008 | 0,24 | 33,54 | 1 332 016 | 555 247 479 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372 860 | 0,20 | 34,60 | 25 815 | 12 902 522 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30 122 | 16 989 872 | 0,18 | 34,60 | 1 042 348 | 587 920 929 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372 114 | 0,20 | 33,73 | 24 964 | 12 553 191 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29 865 | 16 959 750 | 0,18 | 33,73 | 1 007 490 | 572 133 774 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 069 | 371 374 | 0,29 | 34,31 | 36 673 | 12 740 319 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43 131 | 16 929 885 | 0,26 | 34,31 | 1 479 648 | 580 794 942 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370 305 | 0,21 | 33,92 | 26 559 | 12 560 486 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31 617 | 16 886 754 | 0,19 | 33,92 | 1 072 427 | 572 786 875 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369 522 | 0,09 | 34,74 | 11 430 | 12 837 564 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 271 | 16 855 137 | 0,08 | 34,74 | 461 048 | 585 564 315 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 933 | 369 193 | 0,80 | 33,77 | 99 060 | 12 469 235 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118 389 | 16 841 866 | 0,71 | 33,77 | 3 998 506 | 568 822 235 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366 260 | 0,23 | 33,72 | 28 295 | 12 352 009 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33 868 | 16 723 477 | 0,20 | 34,72 | 1 176 056 | 580 717 722 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 534 | 365 421 | 0,42 | 33,98 | 52 118 | 12 415 252 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61 892 | 16 689 609 | 0,37 | 33,98 | 2 102 793 | 567 032 804 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363 887 | 0,17 | 34,01 | 21 190 | 12 376 779 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25 156 | 16 627 717 | 0,15 | 34,01 | 855 623 | 565 553 550 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 228 | 363 264 | 0,34 | 33,40 | 41 020 | 12 134 580 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49 553 | 16 602 561 | 0,30 | 33,40 | 1 655 283 | 554 596 928 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362 036 | 0,27 | 33,54 | 33 007 | 12 143 991 | |
2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 710 | 16 553 008 | 0,24 | 33,54 | 1 332 016 | 555 247 479 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8 000 | 0 | −100,00 | 65,10 | 520 800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8 000 | 0 | −100,00 | 65,10 | 520 800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8 000 | 0 | −100,00 | 65,10 | 520 800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8 000 | 0 | −100,00 | 65,10 | 520 800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8 000 | 0 | −100,00 | 65,10 | 520 800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8 000 | 0 | −100,00 | 65,10 | 520 800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8 000 | 0 | −100,00 | 65,10 | 520 800 | ||
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8 000 | 219 614 | 3,78 | 65,10 | 520 800 | 14 296 871 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8 000 | 219 614 | 3,78 | 65,10 | 520 800 | 14 296 871 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8 000 | 219 614 | 3,78 | 65,10 | 520 800 | 14 296 871 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8 000 | 253 472 | 3,26 | 65,10 | 520 800 | 16 501 027 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8 000 | 1 889 047 | 0,43 | 65,10 | 520 800 | 122 976 960 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8 000 | 208 461 | 3,99 | 65,10 | 520 800 | 13 570 811 | |
2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8 000 | 318 195 | 2,58 | 65,10 | 520 800 | 20 714 494 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303 913 | 0,25 | 26,57 | 19 981 | 8 074 968 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303 913 | 0,25 | 26,57 | 19 981 | 8 074 968 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1 347 295 | 0,06 | 26,57 | 19 981 | 35 797 628 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 11 418 249 | 0,01 | 26,57 | 19 981 | 303 382 876 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1 907 372 | 0,04 | 26,57 | 19 981 | 50 678 874 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 191 202 | 0,39 | 26,57 | 19 981 | 5 080 237 | |
2014-03-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 80 000 | 80 000 | |||||
2014-03-12 |
|
4 | IDP |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 60 000 | 60 000 | |||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 9 031 | 211 614 | 4,46 | 105,75 | 955 028 | 22 378 180 | |
2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 365 969 | 8 172 521 | 4,69 | 105,75 | 38 701 222 | 864 244 096 | |
2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11 738 | 452 540 | 2,66 | 28,50 | 334 533 | 12 897 390 | |
2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 475 644 | 18 476 847 | 2,64 | 28,50 | 13 555 854 | 526 590 140 | |
2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38 934 | 1 552 055 | 2,57 | 28,50 | 1 109 619 | 44 233 568 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303 161 | 0,23 | 29,27 | 19 962 | 8 873 522 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303 161 | 0,23 | 29,27 | 19 962 | 8 873 522 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 11 243 600 | 0,01 | 29,27 | 19 962 | 329 100 172 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 1 732 723 | 0,04 | 29,27 | 19 962 | 50 716 802 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 16 553 | 4,30 | 29,27 | 19 962 | 484 506 | |
2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 177 212 | 0,39 | 29,27 | 19 962 | 5 186 995 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 639 | 361 052 | 0,18 | 39,91 | 25 504 | 14 410 344 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25 596 | 16 513 298 | 0,16 | 39,91 | 1 021 590 | 659 080 401 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 280 | 360 413 | 0,36 | 39,92 | 51 100 | 14 388 372 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 51 244 | 16 487 702 | 0,31 | 39,92 | 2 045 758 | 658 220 390 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 063 | 359 133 | 0,30 | 39,65 | 42 153 | 14 241 383 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42 646 | 16 436 458 | 0,26 | 39,65 | 1 691 123 | 651 786 098 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 486 | 358 070 | 0,70 | 39,70 | 98 694 | 14 215 379 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 99 775 | 16 393 812 | 0,61 | 39,70 | 3 961 068 | 650 834 336 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 377 | 355 584 | 0,39 | 39,54 | 54 442 | 14 058 725 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 55 256 | 16 294 037 | 0,34 | 39,54 | 2 184 656 | 644 217 341 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 056 | 354 207 | 0,87 | 39,53 | 120 798 | 14 001 201 | |
2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 122 660 | 16 238 781 | 0,76 | 39,53 | 4 848 541 | 641 891 407 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 492 | 351 151 | 1,59 | 43,98 | 241 512 | 15 441 935 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 219 958 | 16 116 121 | 1,38 | 43,98 | 9 672 697 | 708 709 644 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 553 | 345 659 | 0,16 | 44,00 | 24 332 | 15 208 823 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22 147 | 15 896 163 | 0,14 | 44,00 | 974 457 | 699 423 224 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 863 | 345 106 | 0,84 | 44,05 | 126 102 | 15 200 366 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 114 663 | 15 874 016 | 0,73 | 44,05 | 5 050 389 | 699 178 972 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170 | 342 243 | 0,05 | 43,42 | 7 382 | 14 861 800 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6 814 | 15 759 353 | 0,04 | 43,42 | 295 896 | 684 345 176 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 512 | 342 073 | 0,74 | 42,95 | 107 883 | 14 691 043 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100 626 | 15 752 539 | 0,64 | 42,95 | 4 321 595 | 676 525 868 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 340 | 339 561 | 0,10 | 43,72 | 14 864 | 14 845 233 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 632 | 15 651 913 | 0,09 | 43,72 | 595 976 | 684 284 419 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 011 | 339 221 | 0,30 | 43,01 | 43 479 | 14 588 403 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40 471 | 15 638 281 | 0,26 | 43,01 | 1 740 480 | 672 533 657 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 818 | 338 210 | 0,54 | 43,20 | 78 547 | 14 612 329 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72 807 | 15 597 810 | 0,47 | 43,20 | 3 145 619 | 673 901 821 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 455 | 336 392 | 0,14 | 43,64 | 19 858 | 14 681 829 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18 232 | 15 525 003 | 0,12 | 43,64 | 795 736 | 677 588 756 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 290 | 335 937 | 0,09 | 42,65 | 12 369 | 14 328 721 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11 617 | 15 506 771 | 0,07 | 42,65 | 495 500 | 661 410 303 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 551 | 335 647 | 1,07 | 42,56 | 151 129 | 14 284 968 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 142 220 | 15 495 154 | 0,93 | 42,56 | 6 052 812 | 659 466 007 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 632 | 332 096 | 0,80 | 42,41 | 111 631 | 14 085 188 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 105 414 | 15 352 934 | 0,69 | 42,41 | 4 470 924 | 651 163 990 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 816 | 329 464 | 0,86 | 42,31 | 119 144 | 13 939 556 | |
2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 112 797 | 15 247 520 | 0,75 | 42,31 | 4 772 419 | 645 119 522 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | −127 000 | 892 000 | −12,46 | 432,60 | −54 940 390 | 385 880 538 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | −4 567 000 | 31 967 000 | −12,50 | 432,60 | −1 975 691 050 | 13 828 972 150 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | −1 084 000 | 7 587 000 | −12,50 | 432,60 | −468 940 026 | 3 282 147 580 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | −2 459 000 | 1 019 000 | −70,70 | 425,88 | −1 047 233 756 | 433 969 580 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | −88 153 000 | 36 534 000 | −70,70 | 425,88 | −37 542 414 519 | 15 559 023 199 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | −20 922 000 | 8 671 000 | −70,70 | 425,88 | −8 910 217 424 | 3 692 787 271 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 170 000 | 6 050 000 | 2,89 | 104,52 | 17 768 043 | 632 333 295 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 6 830 000 | 243 450 000 | 2,89 | 104,52 | 713 857 257 | 25 444 882 755 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 242 000 | 5 880 000 | 4,29 | 104,25 | 25 228 500 | 612 990 000 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 9 758 000 | 236 620 000 | 4,30 | 104,25 | 1 017 271 500 | 24 667 635 000 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 61 000 | 5 638 000 | 1,09 | 103,75 | 6 328 750 | 584 942 500 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 2 439 000 | 226 862 000 | 1,09 | 103,75 | 253 046 250 | 23 536 932 500 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 121 000 | 5 577 000 | 2,22 | 104,75 | 12 674 750 | 584 190 750 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 4 879 000 | 224 423 000 | 2,22 | 104,75 | 511 075 250 | 23 508 309 250 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5 456 000 | 5 456 000 | 100,00 | 545 600 000 | 545 600 000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 5 456 000 | 5 456 000 | 100,00 | 545 600 000 | 545 600 000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 219 544 000 | 219 544 000 | 100,00 | 21 954 400 000 | 21 954 400 000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 219 544 000 | 219 544 000 | 100,00 | 21 954 400 000 | 21 954 400 000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 25 000 000 | 25 000 000 | 100,00 | 2 500 000 000 | 2 500 000 000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 25 000 000 | 25 000 000 | 100,00 | 2 500 000 000 | 2 500 000 000 | ||
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 133 000 | 5 674 000 | 2,40 | 104,09 | 13 844 090 | 590 611 767 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5 367 000 | 228 326 000 | 2,41 | 104,09 | 558 655 860 | 23 766 658 833 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 85 000 | 5 541 000 | 1,56 | 104,12 | 8 850 625 | 576 956 625 | |
2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 3 415 000 | 222 959 000 | 1,56 | 104,12 | 355 586 875 | 23 215 605 875 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 302 479 | 0,22 | 30,33 | 19 957 | 9 174 188 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 11 242 918 | 0,01 | 30,33 | 19 957 | 340 997 703 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 1 732 041 | 0,04 | 30,33 | 19 957 | 52 532 804 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 15 871 | 4,33 | 30,33 | 19 957 | 481 367 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 176 530 | 0,37 | 30,33 | 19 957 | 5 354 155 | |
2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 196 794 | 0,34 | 30,33 | 19 957 | 5 968 762 | |
2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 25 663 | 202 583 | 14,51 | 56,63 | 1 453 296 | 11 472 275 | |
2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1 024 337 | 7 806 552 | 15,10 | 56,63 | 58 008 204 | 442 085 040 | |
2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 21 410 | 510 449 | 4,38 | 3,62 | 77 504 | 1 847 825 | |
2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 1 854 058 | 19 767 770 | 10,35 | 3,62 | 6 711 690 | 71 559 327 | |
2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 882 323 | 2 829 753 | 45,31 | 3,62 | 3 194 009 | 10 243 706 | |
2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 21 410 | 510 449 | 4,38 | 3,62 | 77 504 | 1 847 825 | |
2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 1 854 058 | 19 767 770 | 10,35 | 3,62 | 6 711 690 | 71 559 327 | |
2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 882 323 | 2 829 753 | 45,31 | 3,62 | 3 194 009 | 10 243 706 | |
2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24 705 | 145 533 | 20,45 | 4,40 | 108 702 | 640 345 | |
2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 991 161 | 4 832 285 | 25,80 | 4,40 | 4 361 108 | 21 262 054 | |
2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 120 498 | 1 642 513 | 7,92 | 4,40 | 530 191 | 7 227 057 | |
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301 821 | 0,20 | 32,85 | 19 907 | 9 914 820 | |
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301 821 | 0,20 | 32,85 | 19 907 | 9 914 820 | |
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301 821 | 0,20 | 32,85 | 19 907 | 9 914 820 | |
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 1 731 383 | 0,04 | 32,85 | 19 907 | 56 875 932 | |
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 15 213 | 4,15 | 32,85 | 19 907 | 499 747 | |
2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 175 872 | 0,35 | 32,85 | 19 907 | 5 777 395 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −10 000 | 10 000 | −50,00 | 4,44 | −44 400 | 44 400 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −10 000 | 10 000 | −50,00 | 4,44 | −44 400 | 44 400 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | −10 000 | 10 000 | −50,00 | 4,44 | −44 400 | 44 400 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10 000 | 380 839 | 2,70 | 4,44 | 44 400 | 1 690 925 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10 000 | 380 839 | 2,70 | 4,44 | 44 400 | 1 690 925 | |
2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10 000 | 12 455 783 | 0,08 | 4,44 | 44 400 | 55 303 677 | |
2013-06-13 | 3 | INCY |
INCYTE CORP
Common Stock |
355 839 | ||||||||
2013-06-13 | 3 | INCY |
INCYTE CORP
Common Stock |
15 000 | ||||||||
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16 500 | 16 500 | |||||
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16 500 | 16 500 | |||||
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16 500 | 16 500 | |||||
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16 500 | 16 500 | |||||
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16 500 | 16 500 | |||||
2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16 500 | 16 500 | |||||
2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 500 | 12 500 | |||||
2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 500 | 12 500 | |||||
2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 500 | 12 500 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5 437 | 440 802 | 1,25 | 14,46 | 78 641 | 6 375 804 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217 986 | 18 001 203 | 1,23 | 14,46 | 3 152 971 | 260 371 200 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26 577 | 1 513 121 | 1,79 | 14,46 | 384 412 | 21 885 933 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 3 790 | 435 365 | 0,88 | 14,55 | 55 145 | 6 334 648 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 151 980 | 17 783 217 | 0,86 | 14,55 | 2 211 339 | 258 749 364 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 18 530 | 1 486 544 | 1,26 | 14,55 | 269 615 | 21 629 513 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 4 312 | 431 575 | 1,01 | 14,58 | 62 885 | 6 294 003 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 172 893 | 17 631 237 | 0,99 | 14,58 | 2 521 437 | 257 130 434 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 21 080 | 1 468 014 | 1,46 | 14,58 | 307 427 | 21 409 223 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5 437 | 427 263 | 1,29 | 14,46 | 78 600 | 6 176 728 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217 986 | 17 458 344 | 1,26 | 14,46 | 3 151 315 | 252 386 550 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26 577 | 1 446 934 | 1,87 | 14,46 | 384 210 | 20 917 601 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 775 | 421 826 | 0,66 | 14,42 | 40 004 | 6 081 001 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 111 266 | 17 240 358 | 0,65 | 14,42 | 1 604 000 | 248 535 277 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13 566 | 1 420 357 | 0,96 | 14,42 | 195 566 | 20 475 724 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11 552 | 419 051 | 2,83 | 14,45 | 166 955 | 6 056 335 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 463 197 | 17 129 092 | 2,78 | 14,45 | 6 694 355 | 247 558 202 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56 475 | 1 406 791 | 4,18 | 14,45 | 816 205 | 20 331 647 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 890 | 407 499 | 0,22 | 14,50 | 12 903 | 5 907 798 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 35 702 | 16 665 895 | 0,21 | 14,50 | 517 597 | 241 617 146 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4 353 | 1 350 316 | 0,32 | 14,50 | 63 108 | 19 576 476 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 189 | 406 609 | 1,29 | 14,00 | 72 641 | 5 692 119 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 208 063 | 16 630 193 | 1,27 | 14,00 | 2 912 674 | 232 806 072 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 368 | 1 345 963 | 1,92 | 14,00 | 355 127 | 18 842 136 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11 511 | 401 420 | 2,95 | 14,08 | 162 100 | 5 652 877 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 461 548 | 16 422 130 | 2,89 | 14,08 | 6 499 611 | 231 259 719 | |
2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56 274 | 1 320 595 | 4,45 | 14,08 | 792 462 | 18 596 883 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4 735 | 301 215 | 1,60 | 35,82 | 169 584 | 10 788 015 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 189 886 | 11 241 654 | 1,72 | 35,82 | 6 800 767 | 402 619 838 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23 152 | 1 730 777 | 1,36 | 35,82 | 829 189 | 61 987 778 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3 558 | 296 480 | 1,21 | 36,62 | 130 294 | 10 857 098 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 142 702 | 11 051 768 | 1,31 | 36,62 | 5 225 747 | 404 715 744 | |
2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17 399 | 1 707 625 | 1,03 | 36,62 | 637 151 | 62 533 228 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2 790 | 292 922 | 0,96 | 36,69 | 102 356 | 10 746 400 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 111 907 | 10 909 066 | 1,04 | 36,69 | 4 105 521 | 400 219 813 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13 644 | 1 690 226 | 0,81 | 36,69 | 500 556 | 62 009 152 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1 114 | 290 132 | 0,39 | 36,75 | 40 942 | 10 662 989 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44 627 | 10 797 159 | 0,42 | 36,75 | 1 640 140 | 396 819 347 | |
2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5 501 | 1 676 582 | 0,33 | 36,75 | 202 174 | 61 618 077 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1 021 | 289 018 | 0,35 | 36,82 | 37 595 | 10 642 105 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40 933 | 10 752 532 | 0,38 | 36,82 | 1 507 219 | 395 925 432 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5 046 | 1 671 081 | 0,30 | 36,82 | 185 802 | 61 531 876 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1 613 | 287 997 | 0,56 | 36,93 | 59 574 | 10 636 852 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 64 679 | 10 711 599 | 0,61 | 36,93 | 2 388 848 | 395 621 126 | |
2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7 974 | 1 666 035 | 0,48 | 36,93 | 294 511 | 61 533 170 | |
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11 600 | 11 600 | |||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11 600 | 11 600 | |||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11 600 | 11 600 | |||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8 400 | 489 039 | 1,75 | ||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8 400 | 489 039 | 1,75 | ||||
2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8 400 | 1 947 430 | 0,43 | ||||
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1 358 | 286 384 | 0,48 | 36,93 | 50 154 | 10 576 877 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 54 399 | 10 646 920 | 0,51 | 36,93 | 2 009 091 | 393 217 373 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6 760 | 1 658 061 | 0,41 | 36,93 | 249 664 | 61 236 338 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 332 | 285 026 | 0,12 | 36,99 | 12 280 | 10 542 371 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13 313 | 10 592 521 | 0,13 | 36,99 | 492 413 | 391 789 811 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1 655 | 1 651 301 | 0,10 | 36,99 | 61 214 | 61 077 331 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35 | 284 694 | 0,01 | 36,18 | 1 266 | 10 300 969 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1 392 | 10 579 208 | 0,01 | 36,18 | 50 366 | 382 783 251 | |
2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 173 | 1 649 646 | 0,01 | 36,18 | 6 260 | 59 688 481 | |
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8 750 | 8 750 | |||||
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8 750 | 8 750 | |||||
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8 750 | 8 750 | |||||
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 500 | 326 648 | 1,08 | ||||
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 500 | 326 648 | 1,08 | ||||
2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 500 | 326 648 | 1,08 | ||||
2013-05-21 | 3 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
323 148 | ||||||||
2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43 184 | 389 909 | 12,45 | 12,50 | 539 800 | 4 873 862 | |
2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 730 970 | 15 960 582 | 12,16 | 12,50 | 21 637 125 | 199 507 275 | |
2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218 846 | 1 264 321 | 20,93 | 12,50 | 2 735 575 | 15 804 012 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 418 | 284 659 | 0,15 | 36,54 | 15 273 | 10 401 212 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16 768 | 10 577 816 | 0,16 | 36,54 | 612 689 | 386 504 934 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2 120 | 1 649 473 | 0,13 | 36,54 | 77 463 | 60 270 424 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1 129 | 284 241 | 0,40 | 36,41 | 41 111 | 10 350 295 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 45 279 | 10 561 048 | 0,43 | 36,41 | 1 648 780 | 384 567 890 | |
2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5 725 | 1 647 353 | 0,35 | 36,41 | 208 469 | 59 986 383 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 589 | 283 112 | 0,21 | 35,53 | 20 928 | 10 059 507 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23 610 | 10 515 769 | 0,23 | 35,53 | 838 908 | 373 645 253 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2 985 | 1 641 628 | 0,18 | 35,53 | 106 063 | 58 330 162 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3 516 | 282 523 | 1,26 | 34,02 | 119 609 | 9 610 980 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 140 962 | 10 492 159 | 1,36 | 34,02 | 4 795 302 | 356 926 462 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17 822 | 1 638 643 | 1,10 | 34,02 | 606 276 | 55 744 013 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1 104 | 279 007 | 0,40 | 34,74 | 38 358 | 9 694 098 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44 244 | 10 351 197 | 0,43 | 34,74 | 1 537 258 | 359 652 340 | |
2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5 594 | 1 620 821 | 0,35 | 34,74 | 194 364 | 56 315 426 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277 903 | 0,26 | 27,99 | 19 985 | 7 778 505 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277 903 | 0,26 | 27,99 | 19 985 | 7 778 505 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 10 306 953 | 0,01 | 27,99 | 19 985 | 288 491 614 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 1 615 227 | 0,04 | 27,99 | 19 985 | 45 210 204 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 14 607 | 5,14 | 27,99 | 19 985 | 408 850 | |
2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 175 266 | 0,41 | 27,99 | 19 985 | 4 905 695 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 612 | 277 189 | 0,22 | 27,63 | 16 912 | 7 659 813 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24 508 | 10 306 239 | 0,24 | 27,64 | 677 325 | 284 832 497 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3 080 | 1 614 513 | 0,19 | 27,64 | 85 122 | 44 620 134 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 453 | 276 577 | 0,16 | 27,97 | 12 672 | 7 736 744 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 18 151 | 10 281 731 | 0,18 | 27,97 | 507 742 | 287 612 918 | |
2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2 281 | 1 611 433 | 0,14 | 27,97 | 63 807 | 45 076 938 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 758 | 276 124 | 0,28 | 28,43 | 21 551 | 7 850 509 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 30 102 | 10 263 580 | 0,29 | 28,43 | 855 833 | 291 804 869 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3 940 | 1 609 152 | 0,25 | 28,43 | 112 019 | 45 749 961 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 375 | 275 366 | 0,14 | 28,58 | 10 718 | 7 870 098 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14 878 | 10 233 478 | 0,15 | 28,58 | 425 221 | 292 477 918 | |
2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1 947 | 1 605 212 | 0,12 | 28,58 | 55 646 | 45 877 762 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1 742 | 274 991 | 0,64 | 28,23 | 49 180 | 7 763 463 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 69 187 | 10 218 600 | 0,68 | 28,23 | 1 953 267 | 288 488 450 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9 055 | 1 603 265 | 0,57 | 28,23 | 255 638 | 45 262 897 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 788 | 273 249 | 0,29 | 27,96 | 22 033 | 7 640 288 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31 584 | 10 149 413 | 0,31 | 27,96 | 883 117 | 283 786 722 | |
2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4 004 | 1 594 210 | 0,25 | 27,96 | 111 955 | 44 575 546 | |
2013-01-23 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2013-01-23 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
346 725 | ||||||||
2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 20 099 | 176 920 | 12,82 | 47,53 | 955 305 | 8 409 008 | |
2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 839 621 | 6 782 215 | 14,13 | 47,53 | 39 907 186 | 322 358 679 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 272 461 | 0,13 | 27,24 | 9 997 | 7 421 838 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 272 461 | 0,13 | 27,24 | 9 997 | 7 421 838 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 10 117 829 | 0,00 | 27,24 | 9 997 | 275 609 662 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 1 590 206 | 0,02 | 27,24 | 9 997 | 43 317 211 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 13 893 | 2,71 | 27,24 | 9 997 | 378 445 | |
2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 174 552 | 0,21 | 27,24 | 9 997 | 4 754 796 | |
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6 | 271 806 | 0,00 | 27,54 | 165 | 7 485 537 | |
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 268 | 10 117 174 | 0,00 | 27,54 | 7 381 | 278 626 972 | |
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26 | 1 589 551 | 0,00 | 27,54 | 716 | 43 776 235 | |
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4 859 | 271 800 | 1,82 | 26,83 | 130 352 | 7 291 551 | |
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 202 311 | 10 116 906 | 2,04 | 26,83 | 5 427 377 | 271 405 226 | |
2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 21 830 | 1 589 525 | 1,39 | 26,83 | 585 631 | 42 642 028 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2 223 | 266 941 | 0,84 | 27,32 | 60 725 | 7 291 894 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92 592 | 9 914 595 | 0,94 | 27,32 | 2 529 289 | 270 832 034 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8 352 | 1 567 695 | 0,54 | 27,32 | 228 147 | 42 823 940 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2 231 | 264 718 | 0,85 | 27,99 | 62 450 | 7 409 960 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92 917 | 9 822 003 | 0,96 | 27,99 | 2 600 923 | 274 936 526 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8 691 | 1 559 343 | 0,56 | 27,99 | 243 278 | 43 648 973 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4 298 | 262 487 | 1,66 | 27,94 | 120 075 | 7 333 204 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 178 978 | 9 729 086 | 1,87 | 27,94 | 5 000 180 | 271 805 367 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16 724 | 1 550 652 | 1,09 | 27,94 | 467 225 | 43 321 185 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143 | 258 189 | 0,06 | 27,86 | 3 983 | 7 192 010 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24 | 258 046 | 0,01 | 26,68 | 640 | 6 884 693 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 79 | 258 022 | 0,03 | 27,16 | 2 146 | 7 008 187 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9 905 | 257 943 | 3,99 | 27,84 | 275 793 | 7 182 113 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 651 | 248 038 | 0,26 | 26,91 | 17 516 | 6 673 735 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 324 | 247 387 | 0,13 | 25,83 | 8 367 | 6 388 868 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5 972 | 9 550 108 | 0,06 | 27,86 | 166 354 | 266 023 988 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 980 | 9 544 136 | 0,01 | 26,68 | 26 146 | 254 638 503 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3 298 | 9 543 156 | 0,03 | 27,16 | 89 578 | 259 203 569 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 412 596 | 9 539 858 | 4,52 | 27,84 | 11 488 241 | 265 625 898 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 27 125 | 9 127 262 | 0,30 | 26,91 | 729 828 | 245 579 024 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13 447 | 9 100 137 | 0,15 | 25,83 | 347 274 | 235 014 678 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 585 | 1 533 928 | 0,04 | 27,86 | 16 296 | 42 728 485 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 96 | 1 533 343 | 0,01 | 26,68 | 2 561 | 40 909 745 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 323 | 1 533 247 | 0,02 | 27,16 | 8 773 | 41 644 828 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40 412 | 1 532 924 | 2,71 | 27,84 | 1 125 224 | 42 682 429 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2 657 | 1 492 512 | 0,18 | 26,91 | 71 490 | 40 157 677 | |
2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1 316 | 1 489 855 | 0,09 | 25,83 | 33 986 | 38 476 101 | |
2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 103 608 | 463 839 | 28,76 | 3,00 | 310 824 | 1 391 517 | |
2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 4 282 419 | 17 888 512 | 31,47 | 3,00 | 12 847 257 | 53 665 536 | |
2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 336 639 | 1 922 230 | 21,23 | 3,00 | 1 009 917 | 5 766 690 | |
2012-07-31 | 3 | GHDX |
GENOMIC HEALTH INC
Common Stock |
247 063 | ||||||||
2012-07-23 | 3 | XOMA |
XOMA Corp
Common Stock |
360 231 | ||||||||
2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 21 082 | 156 821 | 15,53 | 41,20 | 868 578 | 6 461 025 | |
2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 864 918 | 5 942 594 | 17,03 | 41,20 | 35 634 622 | 244 834 873 | |
2012-07-13 | 3 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
135 739 |